<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>B-cell chronic lymphocytic leukemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/B-cell_chronic_lymphocytic_leukemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"B-cell_chronic_lymphocytic_leukemia","wgTitle":"B-cell chronic lymphocytic leukemia","wgCurRevisionId":670152435,"wgRevisionId":670152435,"wgArticleId":454231,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages using citations with accessdate and no URL","Articles with contributors link","All accuracy disputes","Articles with disputed statements from February 2015","All articles with unsourced statements","Articles with unsourced statements from July 2008","Articles with unsourced statements from July 2013","Articles that use a Medicine navs subtemplate","Chronic lymphocytic leukemia","Small blue round cell tumor"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"B-cell_chronic_lymphocytic_leukemia","wgRelevantArticleId":454231,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Chronic_lymphocytic_leukemia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Chronic_lymphocytic_leukemia.jpg/100px-Chronic_lymphocytic_leukemia.jpg","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/B-cell_chronic_lymphocytic_leukemia","wgWikibaseItemId":"Q1088156"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-B-cell_chronic_lymphocytic_leukemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">B-cell chronic lymphocytic leukemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Chronic_lymphocytic_leukemia&amp;redirect=no" title="Chronic lymphocytic leukemia">Chronic lymphocytic leukemia</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="hatnote">"B-cell CLL" redirects here. For the gene family, see <a href="/wiki/B-cell_CLL/lymphoma" title="B-cell CLL/lymphoma">B-cell CLL/lymphoma</a>.</div>
<table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Chronic lymphocytic leukemia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Chronic_lymphocytic_leukemia.jpg" class="image"><img alt="Chronic lymphocytic leukemia.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Chronic_lymphocytic_leukemia.jpg/230px-Chronic_lymphocytic_leukemia.jpg" width="230" height="173" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Chronic_lymphocytic_leukemia.jpg/345px-Chronic_lymphocytic_leukemia.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Chronic_lymphocytic_leukemia.jpg/460px-Chronic_lymphocytic_leukemia.jpg 2x" data-file-width="2004" data-file-height="1510" /></a>
<div>Peripheral blood smear showing CLL cells</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Hematology" title="Hematology">Hematology</a> and <a href="/wiki/Oncology" title="Oncology">oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C91.1">C91.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=204.1">V10.60 204.1 V10.60</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I98233/">9823/3</a> (CLL)<br />
9670/3 (SCL)</td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb2641.htm">2641</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000532.htm">000532</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic370.htm">med/370</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">NCI</a></th>
<td><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/leukemia">B-cell chronic lymphocytic leukemia</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D015451">D015451</a></td>
</tr>
</table>
<p><b>B-cell chronic lymphocytic leukemia</b> (<b>B-CLL</b>), also known as <b>chronic lymphoid leukemia</b> (CLL), is the most common type of <a href="/wiki/Leukemias" title="Leukemias" class="mw-redirect">leukemia</a> (a type of cancer of the <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a>) in adults.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup> CLL affects <a href="/wiki/B_cell" title="B cell">B cell</a> <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a>, which originate in the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a>, develop in the <a href="/wiki/Lymph_nodes" title="Lymph nodes" class="mw-redirect">lymph nodes</a>, and normally fight infection by producing <a href="/wiki/Antibodies" title="Antibodies" class="mw-redirect">antibodies</a>.</p>
<p>In CLL, B cells grow out of control and accumulate in the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> and <a href="/wiki/Blood" title="Blood">blood</a>, where they crowd out healthy <a href="/wiki/Blood_cells" title="Blood cells" class="mw-redirect">blood cells</a>. CLL is a <a href="/wiki/Cancer_staging" title="Cancer staging">stage</a> of <b>small lymphocytic lymphoma</b> (SLL), a type of <a href="/wiki/B-cell_lymphoma" title="B-cell lymphoma">B-cell lymphoma</a>, which presents primarily in the <a href="/wiki/Lymph_nodes" title="Lymph nodes" class="mw-redirect">lymph nodes</a>.<sup id="cite_ref-pmid10577857_2-0" class="reference"><a href="#cite_note-pmid10577857-2"><span>[</span>2<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Disputed_statement" title="Wikipedia:Disputed statement" class="mw-redirect"><span title="The material near this tag is possibly inaccurate or nonfactual. (February 2015)">dubious</span></a> <span class="metadata">– <a href="/wiki/Talk:B-cell_chronic_lymphocytic_leukemia#Dubious" title="Talk:B-cell chronic lymphocytic leukemia">discuss</a></span></i>]</sup> CLL and SLL are considered the same underlying disease, just with different appearances.<sup id="cite_ref-Williams_2010_8_3-0" class="reference"><a href="#cite_note-Williams_2010_8-3"><span>[</span>3<span>]</span></a></sup><sup class="reference" style="white-space:nowrap;">:1441</sup></p>
<p>CLL is a disease of adults. Most (&gt;75%) people newly diagnosed with CLL are over the age of 50, and the majority are men. However, in rare cases, it can occur in teenagers and occasionally in children. Some of these may relate to an inherited predisposition.</p>
<p>Most people are diagnosed without symptoms as the result of a routine blood test that returns a high white blood cell count, but, as it advances, CLL results in <a href="/wiki/Swollen_lymph_nodes" title="Swollen lymph nodes" class="mw-redirect">swollen lymph nodes</a>, <a href="/wiki/Splenomegaly" title="Splenomegaly">spleen</a>, and <a href="/wiki/Hepatomegaly" title="Hepatomegaly">liver</a>, and eventually <a href="/wiki/Anemia" title="Anemia">anemia</a> and infections. Early CLL is not treated, and late CLL is treated with chemotherapy and <a href="/wiki/Monoclonal_antibodies" title="Monoclonal antibodies" class="mw-redirect">monoclonal antibodies</a>.</p>
<p>DNA analysis has distinguished two major types of CLL, with different survival times. CLL that is positive for the marker <a href="/wiki/ZAP-70" title="ZAP-70" class="mw-redirect">ZAP-70</a> has an average survival of 8 years, while CLL negative for ZAP-70 has an average survival of more than 25 years. Many patients, especially older ones, with slowly progressing disease can be reassured and may not need any treatment in their lifetimes.<sup id="cite_ref-pmid15728813_4-0" class="reference"><a href="#cite_note-pmid15728813-4"><span>[</span>4<span>]</span></a></sup></p>
<div class="toclimit-3">
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Diagnosis"><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Clinical_staging"><span class="tocnumber">2.1</span> <span class="toctext">Clinical staging</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Gene_mutation_status"><span class="tocnumber">2.2</span> <span class="toctext">Gene mutation status</span></a>
<ul>
<li class="toclevel-3 tocsection-5"><a href="#IgVH_mutation_status"><span class="tocnumber">2.2.1</span> <span class="toctext">IgV<sub>H</sub> mutation status</span></a></li>
<li class="toclevel-3 tocsection-6"><a href="#Chromosomal_abnormalities"><span class="tocnumber">2.2.2</span> <span class="toctext">Chromosomal abnormalities</span></a></li>
<li class="toclevel-3 tocsection-7"><a href="#Array-based_karyotyping"><span class="tocnumber">2.2.3</span> <span class="toctext">Array-based karyotyping</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-8"><a href="#Related_diseases"><span class="tocnumber">2.3</span> <span class="toctext">Related diseases</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Differential_diagnosis"><span class="tocnumber">2.4</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-10"><a href="#Treatment"><span class="tocnumber">3</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#During_pregnancy"><span class="tocnumber">3.1</span> <span class="toctext">During pregnancy</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Decision_to_treat"><span class="tocnumber">3.2</span> <span class="toctext">Decision to treat</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Chemotherapy"><span class="tocnumber">3.3</span> <span class="toctext">Chemotherapy</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Targeted_therapy"><span class="tocnumber">3.4</span> <span class="toctext">Targeted therapy</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Stem_cell_transplantation"><span class="tocnumber">3.5</span> <span class="toctext">Stem cell transplantation</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Refractory_CLL"><span class="tocnumber">3.6</span> <span class="toctext">Refractory CLL</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-17"><a href="#Complications"><span class="tocnumber">4</span> <span class="toctext">Complications</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#Epidemiology"><span class="tocnumber">5</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#Research_directions"><span class="tocnumber">7</span> <span class="toctext">Research directions</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#See_also"><span class="tocnumber">8</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-23"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_the_cells_CLL_afects_CRUK_296.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/28/Diagram_showing_the_cells_CLL_afects_CRUK_296.svg/220px-Diagram_showing_the_cells_CLL_afects_CRUK_296.svg.png" width="220" height="439" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/28/Diagram_showing_the_cells_CLL_afects_CRUK_296.svg/330px-Diagram_showing_the_cells_CLL_afects_CRUK_296.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/28/Diagram_showing_the_cells_CLL_afects_CRUK_296.svg/440px-Diagram_showing_the_cells_CLL_afects_CRUK_296.svg.png 2x" data-file-width="207" data-file-height="413" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_the_cells_CLL_afects_CRUK_296.svg" class="internal" title="Enlarge"></a></div>
A diagram showing the cells affected by CLL</div>
</div>
</div>
<p>Most people are diagnosed without symptoms as the result of a routine blood test that returns a high white blood cell count. Less commonly, CLL may present with enlarged lymph nodes without a high white blood cell count or no evidence of the disease in the blood. This is referred to as <i>small lymphocytic lymphoma</i>. In some individuals the disease comes to light only after the neoplastic cells overwhelm the bone marrow resulting in anemia producing tiredness or weakness.</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=2" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Chronic_lymphocytic_leukemia_-_high_mag.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Chronic_lymphocytic_leukemia_-_high_mag.jpg/220px-Chronic_lymphocytic_leukemia_-_high_mag.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Chronic_lymphocytic_leukemia_-_high_mag.jpg/330px-Chronic_lymphocytic_leukemia_-_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/24/Chronic_lymphocytic_leukemia_-_high_mag.jpg/440px-Chronic_lymphocytic_leukemia_-_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Chronic_lymphocytic_leukemia_-_high_mag.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of a <a href="/wiki/Lymph_node" title="Lymph node">lymph node</a> affected by B-CLL showing a characteristic proliferation center (right of image), composed of larger, lighter staining, cells. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a>.</div>
</div>
</div>
<p>CLL is usually first suspected by the presence of <a href="/wiki/Lymphocytosis" title="Lymphocytosis">lymphocytosis</a>, an increase in a type of white blood cell, on a complete blood count (CBC) test. This frequently is an incidental finding on a routine physician visit. Most often the lymphocyte count is greater than 4000 cells per microliter (µl) of blood, but can be much higher. The presence of a lymphocytosis in an elderly individual should raise strong suspicion for CLL, and a confirmatory diagnostic test, in particular flow cytometry, should be performed unless clinically unnecessary.</p>
<p>The diagnosis of CLL is based on the demonstration of an abnormal population of B lymphocytes in the blood, bone marrow, or tissues that display an unusual but characteristic pattern of molecules on the cell surface. This atypical molecular pattern includes the coexpression of cells surface markers <a href="/wiki/Cluster_of_differentiation" title="Cluster of differentiation">cluster of differentiation</a> <a href="/wiki/CD5_(protein)" title="CD5 (protein)">5</a> (<a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a>) and <a href="/wiki/Cluster_of_differentiation" title="Cluster of differentiation">cluster of differentiation</a> <a href="/wiki/CD23" title="CD23">23</a> (<a href="/wiki/CD23" title="CD23">CD23</a>). In addition, all the CLL cells within one individual are clonal, that is, genetically identical. In practice, this is inferred by the detection of only one of the mutually exclusive <a href="/wiki/Immunoglobulin_light_chain" title="Immunoglobulin light chain">antibody light chains</a>, kappa or lambda, on the entire population of the abnormal B cells. Normal B lymphocytes consist of a stew of different antibody-producing cells, resulting in a mixture of both kappa and lambda expressing cells. The lack of the normal distribution of kappa and lambda producing B cells is one basis for demonstrating clonality, the key element for establishing a diagnosis of any B cell malignancy (B cell non-Hodgkin lymphoma).</p>
<p>The combination of the microscopic examination of the peripheral blood and analysis of the lymphocytes by <a href="/wiki/Flow_cytometry" title="Flow cytometry">flow cytometry</a> to confirm clonality and marker molecule expression is needed to establish the diagnosis of CLL. Both are easily accomplished on a small amount of blood. A <a href="/wiki/Flow_cytometer" title="Flow cytometer" class="mw-redirect">flow cytometer</a> is an instrument that can examine the expression of molecules on individual cells in fluids. This requires the use of specific antibodies to marker molecules with fluorescent tags recognized by the instrument. In CLL, the lymphocytes are genetically clonal, of the B cell lineage (expressing marker molecules <a href="/wiki/Cluster_of_differentiation" title="Cluster of differentiation">cluster of differentiation</a> <a href="/wiki/CD19" title="CD19">19</a> (<a href="/wiki/CD19" title="CD19">CD19</a>) and <a href="/wiki/CD20" title="CD20">CD20</a>), and characteristically express the marker molecules <a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a> and <a href="/wiki/CD23" title="CD23">CD23</a>. These B cells resemble normal lymphocytes under the microscope, although slightly smaller, and are fragile when smeared onto a glass slide, giving rise to many broken cells, which are called "smudge" or "smear" cells.<sup id="cite_ref-isbn1-4051-4265-0_5-0" class="reference"><a href="#cite_note-isbn1-4051-4265-0-5"><span>[</span>5<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Smear_cells.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Smear_cells.jpg/220px-Smear_cells.jpg" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Smear_cells.jpg/330px-Smear_cells.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Smear_cells.jpg/440px-Smear_cells.jpg 2x" data-file-width="2560" data-file-height="1920" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Smear_cells.jpg" class="internal" title="Enlarge"></a></div>
Smudge cells in peripheral blood</div>
</div>
</div>
<p>The Matutes's CLL score allows the identification of a homogeneous subgroup of classical CLL, that differs from atypical/mixed CLL for the five markers' expression (CD5, CD23, FMC7, CD22 and immunoglobulin light chain) Matutes's CLL scoring system is very helpful for the differential diagnosis between classical CLL and the other B cell chronic lymphoproliferative disorders, but not for the immunological distinction between mixed/atypical CLL and <a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">mantle cell lymphoma</a> (MCL malignant B cells).<sup id="cite_ref-pmid7523797_6-0" class="reference"><a href="#cite_note-pmid7523797-6"><span>[</span>6<span>]</span></a></sup> Discrimination between CLL and MCL can be improved by adding non-routine markers such as CD54<sup id="cite_ref-CD54_7-0" class="reference"><a href="#cite_note-CD54-7"><span>[</span>7<span>]</span></a></sup> and CD200.<sup id="cite_ref-CD200_8-0" class="reference"><a href="#cite_note-CD200-8"><span>[</span>8<span>]</span></a></sup> Among routine markers, the most discriminating feature is the CD20/CD23 mean fluorescence intensity ratio. In contrast, FMC7 expression can surprisingly be misleading for borderline cases.<sup id="cite_ref-MCL-CLL_9-0" class="reference"><a href="#cite_note-MCL-CLL-9"><span>[</span>9<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Clinical_staging">Clinical staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=3" title="Edit section: Clinical staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Staging, determining the extent of the disease, is done with the Rai staging system or the Binet classification (see details<sup id="cite_ref-NCI-CLL-page2_10-0" class="reference"><a href="#cite_note-NCI-CLL-page2-10"><span>[</span>10<span>]</span></a></sup>) and is based primarily on the presence of a low platelet or red cell count. Early stage disease does not need to be treated.</p>
<p><b>Rai Staging System</b><sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup></p>
<ul>
<li><i>Stage 0</i>: characterized by absolute lymphocytosis (&gt;15,000/mm3) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia.</li>
<li><i>Stage I</i>: characterized by absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia.</li>
<li><i>Stage II:</i> characterized by absolute lymphocytosis with either hepatomegaly or splenomegaly with or without lymphadenopathy.</li>
<li><i>Stage III</i>: characterized by absolute lymphocytosis and anemia (hemoglobin &lt;11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly.</li>
<li><i>Stage IV</i>: characterized by absolute lymphocytosis and thrombocytopenia (&lt;100,000/mm3) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia.</li>
</ul>
<p><b>Binet Classification</b><sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<ul>
<li><i>Clinical stage A</i>: characterized by no anemia or thrombocytopenia and fewer than three areas of lymphoid involvement (Rai stages 0, I, and II).</li>
<li><i>Clinical stage B</i>: characterized by no anemia or thrombocytopenia with three or more areas of lymphoid involvement (Rai stages I and II).</li>
<li><i>Clinical stage C</i>: characterized by anemia and/or thrombocytopenia regardless of the number of areas of lymphoid enlargement (Rai stages III and IV).</li>
</ul>
<h3><span class="mw-headline" id="Gene_mutation_status">Gene mutation status</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=4" title="Edit section: Gene mutation status">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="IgVH_mutation_status">IgV<sub>H</sub> mutation status</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=5" title="Edit section: IgVH mutation status">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Prognosis varies greatly depending on which diagnostic group CLL falls into. There are two<sup id="cite_ref-pmid11733578_14-0" class="reference"><a href="#cite_note-pmid11733578-14"><span>[</span>14<span>]</span></a></sup> or three<sup id="cite_ref-pmid12406914_15-0" class="reference"><a href="#cite_note-pmid12406914-15"><span>[</span>15<span>]</span></a></sup> prognostic groups based on the maturational state of the cell. This distinction is based on the maturity of the lymphocytes as discerned by the immunoglobulin variable-region <a href="/wiki/Heavy_chain" title="Heavy chain">heavy chain</a> (IgV<sub>H</sub>) gene mutation status.<sup id="cite_ref-pmid16983131_16-0" class="reference"><a href="#cite_note-pmid16983131-16"><span>[</span>16<span>]</span></a></sup> High risk patients have an immature cell pattern with few mutations in the DNA in the IgV<sub>H</sub> antibody gene region whereas low risk patients show considerable mutations of the DNA in the antibody gene region indicating mature lymphocytes.<sup id="cite_ref-pmid10477713_17-0" class="reference"><a href="#cite_note-pmid10477713-17"><span>[</span>17<span>]</span></a></sup> Moreover, usage of specific subgenes (i.e. V3-21) for variable segment of immunoglobulin is a marker for more severe prognosis.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> The usage of certain variable segments (i.e. V2 family) is also connected to the activation of microRNA miR-650, which further influences the biology of CLL.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup></p>
<p>Since assessment of the IgV<sub>H</sub> antibody DNA changes is difficult to perform, the presence of either <a href="/wiki/Cluster_of_differentiation" title="Cluster of differentiation">cluster of differentiation</a> <a href="/wiki/CD38" title="CD38">38</a> (<a href="/wiki/CD38" title="CD38">CD38</a>) or Z-chain–associated protein kinase-70 (<a href="/wiki/ZAP-70" title="ZAP-70" class="mw-redirect">ZAP-70</a>) may be surrogate markers of high risk subtype of CLL.<sup id="cite_ref-pmid16983131_16-1" class="reference"><a href="#cite_note-pmid16983131-16"><span>[</span>16<span>]</span></a></sup> Their expression correlates with a more immature cellular state and a more rapid disease course.</p>
<h4><span class="mw-headline" id="Chromosomal_abnormalities">Chromosomal abnormalities</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=6" title="Edit section: Chromosomal abnormalities">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>In addition to the immunoglobulin variable-region <a href="/wiki/Heavy_chain" title="Heavy chain">heavy chain</a> (IgV<sub>H</sub>) gene mutation status, the prognosis of patients with CLL is dependent on the genetic changes within the neoplastic cell population. These genetic changes can be identified by fluorescent probes to chromosomal parts using a technique referred to as <a href="/wiki/Fluorescent_in_situ_hybridization" title="Fluorescent in situ hybridization" class="mw-redirect">fluorescent in situ hybridization</a> (FISH).<sup id="cite_ref-pmid16983131_16-2" class="reference"><a href="#cite_note-pmid16983131-16"><span>[</span>16<span>]</span></a></sup> Four main genetic aberrations are recognized in CLL cells that have a major impact on disease behavior.<sup id="cite_ref-pmid11136261_20-0" class="reference"><a href="#cite_note-pmid11136261-20"><span>[</span>20<span>]</span></a></sup></p>
<ol>
<li>Deletions of part of the short arm of chromosome 17 (del 17p), which target the cell cycle regulating protein p53 are particularly deleterious. The deletion of p53 leads to deregulation of numerous genes including microRNAs (miR-34a).<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup> Patients with this abnormality have significantly short interval before they require therapy and a shorter survival. This abnormality is found in 5–10% of patients with CLL.</li>
<li>Deletions of the long arm on chromosome 11 (del 11q) are also unfavorable although not to the degree seen with del 17p. The abnormality targets the ATM gene and occurs infrequently in CLL (5–10%).</li>
<li>Trisomy 12, an additional chromosome 12, is a relatively frequent finding occurring in 20–25% of patients and imparts an intermediate prognosis.</li>
<li>Deletion of the long arm of chromosome 13 (del 13q) is the most common abnormality in CLL with roughly 50% of patients with cells containing this defect. These patients have the best prognosis and most will live many years, even decades, without the need for therapy. The gene targeted by this deletion is a segment coding for microRNAs miR-15a and miR-16-1.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup> Studies have found the miR-15a/16-1 microRNA cluster to function as a tumour suppressor, with the oncogene BCL2 as its target.<sup id="cite_ref-pmid18931683_24-0" class="reference"><a href="#cite_note-pmid18931683-24"><span>[</span>24<span>]</span></a></sup></li>
</ol>
<p>It was described that in malignant B cells miRNAs participate in pathways fundamental to B cell development like B cell receptor (BCR) signalling, B cell migration/adhesion, cell-cell interactions in immune niches, and the production and class-switching of immunoglobulins. MiRNAs influence B cell maturation, generation of pre-, marginal zone, follicular, B1, plasma and memory B cells.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Array-based_karyotyping">Array-based karyotyping</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=7" title="Edit section: Array-based karyotyping">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Array-based karyotyping is a cost-effective alternative to FISH for detecting chromosomal abnormalities in CLL. Several clinical validation studies have shown &gt;95% concordance with the standard CLL FISH panel.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> See also <a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">Virtual Karyotype</a>.</p>
<h3><span class="mw-headline" id="Related_diseases">Related diseases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=8" title="Edit section: Related diseases">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the past, cases with similar microscopic appearance in the blood but with a T cell phenotype were referred to as T-cell CLL. However, these are now recognized as a separate disease group and are currently classified as <a href="/wiki/T-cell_prolymphocytic_leukemia" title="T-cell prolymphocytic leukemia">T-cell prolymphocytic leukemias</a>.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-pmid10442186_32-0" class="reference"><a href="#cite_note-pmid10442186-32"><span>[</span>32<span>]</span></a></sup></p>
<p>CLL should not be confused with <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">acute lymphoblastic leukemia</a> (ALL), a highly aggressive leukemia most commonly diagnosed in children, and highly treatable in the pediatric setting.</p>
<h3><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=9" title="Edit section: Differential diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<table class="wikitable">
<tr>
<th>Lymphoid disorders that can present as <i>chronic leukemia</i> and can be confused with <i>typical B-cell chronic lymphoid leukemia</i><sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup></th>
</tr>
<tr>
<td><a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular lymphoma</a></td>
</tr>
<tr>
<td><a href="/wiki/Splenic_marginal_zone_lymphoma" title="Splenic marginal zone lymphoma">Splenic marginal zone lymphoma</a></td>
</tr>
<tr>
<td><a href="/w/index.php?title=Nodal_marginal_zone_lymphoma&amp;action=edit&amp;redlink=1" class="new" title="Nodal marginal zone lymphoma (page does not exist)">Nodal marginal zone lymphoma</a></td>
</tr>
<tr>
<td><a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell lymphoma</a></td>
</tr>
<tr>
<td><a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a></td>
</tr>
<tr>
<td><a href="/wiki/Prolymphocytic_leukemia" title="Prolymphocytic leukemia">Prolymphocytic leukemia</a> (B cell or T cell)</td>
</tr>
<tr>
<td><a href="/wiki/Lymphoplasmacytic_lymphoma" title="Lymphoplasmacytic lymphoma" class="mw-redirect">Lymphoplasmacytic lymphoma</a></td>
</tr>
<tr>
<td><a href="/wiki/S%C3%A9zary_syndrome" title="Sézary syndrome" class="mw-redirect">Sézary syndrome</a></td>
</tr>
<tr>
<td><a href="/w/index.php?title=Smoldering_adult_T_cell_leukemia&amp;action=edit&amp;redlink=1" class="new" title="Smoldering adult T cell leukemia (page does not exist)">Smoldering adult T cell leukemia</a>/lymphoma</td>
</tr>
</table>
<p>Hematologic disorders that may resemble CLL in their clinical presentation, behavior, and microscopic appearance include mantle cell lymphoma, marginal zone lymphoma, B cell prolymphocytic leukemia, and lymphoplasmacytic lymphoma.</p>
<ul>
<li><a href="/wiki/B_cell_prolymphocytic_leukemia" title="B cell prolymphocytic leukemia" class="mw-redirect">B cell prolymphocytic leukemia</a> (B PLL), a related, but more aggressive disorder, has cells with similar phenotype, but are significantly larger than normal lymphocytes and have a prominent nucleolus. The distinction is important as the prognosis and therapy differs from CLL.</li>
<li><a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a> is also a neoplasm of B lymphocytes, but the neoplastic cells have a distinct morphology under the microscope (hairy cell leukemia cells have delicate, hair-like projections on their surface) and unique marker molecule expression.</li>
</ul>
<p>All the B cell malignancies of the blood and bone marrow can be differentiated from one another by the combination of cellular microscopic morphology, marker molecule expression, and specific tumor-associated gene defects. This is best accomplished by evaluation of the patient's blood, bone marrow and occasionally lymph node cells by a <a href="/wiki/Pathologist" title="Pathologist" class="mw-redirect">pathologist</a> with specific training in blood disorders. A flow cytometer is necessary for cell marker analysis, and the detection of genetic problems in the cells may require visualizing the DNA changes with fluorescent probes by <a href="/wiki/Fluorescent_in_situ_hybridization" title="Fluorescent in situ hybridization" class="mw-redirect">FISH</a>.</p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=10" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>CLL treatment focuses on controlling the disease and its symptoms rather than on an outright cure. CLL is treated by <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Biological_therapy" title="Biological therapy" class="mw-redirect">biological therapy</a>, or <a href="/wiki/Bone_marrow_transplantation" title="Bone marrow transplantation" class="mw-redirect">bone marrow transplantation</a>. Symptoms are sometimes treated surgically (<a href="/wiki/Splenectomy" title="Splenectomy">splenectomy</a> removal of enlarged spleen) or by <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> ("de-bulking" swollen lymph nodes).</p>
<p>Initial CLL treatments vary depending on the exact diagnosis and the progression of the disease, and even with the preference and experience of the health care practitioner. Dozens of agents are used for CLL therapy.<sup id="cite_ref-PDQ_34-0" class="reference"><a href="#cite_note-PDQ-34"><span>[</span>34<span>]</span></a></sup> An initial treatment regimen that contains <a href="/wiki/Fludarabine" title="Fludarabine">fludarabine</a>, <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, and <a href="/wiki/Rituximab" title="Rituximab">rituximab</a> (known as FCR) has demonstrated higher overall response rates and complete response rates.<sup id="cite_ref-CTO_35-0" class="reference"><a href="#cite_note-CTO-35"><span>[</span>35<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="During_pregnancy">During pregnancy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=11" title="Edit section: During pregnancy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Leukemia is rarely associated with pregnancy, affecting only about 1 in 10,000 pregnant women.<sup id="cite_ref-Shapira_36-0" class="reference"><a href="#cite_note-Shapira-36"><span>[</span>36<span>]</span></a></sup> Treatment for chronic lymphocytic leukemias can often be postponed until after the end of the pregnancy. If treatment is necessary, then giving chemotherapy during the second or third trimesters is less likely to result in <a href="/wiki/Pregnancy_loss" title="Pregnancy loss" class="mw-redirect">pregnancy loss</a> or <a href="/wiki/Birth_defect" title="Birth defect" class="mw-redirect">birth defects</a> than treatment during the <a href="/wiki/First_trimester" title="First trimester" class="mw-redirect">first trimester</a>.<sup id="cite_ref-Shapira_36-1" class="reference"><a href="#cite_note-Shapira-36"><span>[</span>36<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Decision_to_treat">Decision to treat</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=12" title="Edit section: Decision to treat">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>While generally considered incurable, CLL progresses slowly in most cases. Many people with CLL lead normal and active lives for many years—in some cases for decades. Because of its slow onset, early-stage CLL is, in general, not treated since it is believed that early CLL intervention does not improve survival time or quality of life. Instead, the condition is monitored over time to detect any change in the disease pattern.<sup id="cite_ref-CTO_35-1" class="reference"><a href="#cite_note-CTO-35"><span>[</span>35<span>]</span></a></sup></p>
<p>The decision to start CLL treatment is taken when the patient's clinical symptoms or blood counts indicate that the disease has progressed to a point where it may affect the patient's quality of life.</p>
<p>Clinical "staging systems" such as the Rai 4-stage system and the Binet classification can help to determine when and how to treat the patient.<sup id="cite_ref-NCI-CLL-page2_10-1" class="reference"><a href="#cite_note-NCI-CLL-page2-10"><span>[</span>10<span>]</span></a></sup></p>
<p>Determining when to start treatment and by what means is often difficult; studies have shown there is no survival advantage to treating the disease too early. The National Cancer Institute Working Group has issued guidelines for treatment, with specific markers that should be met before it is initiated.<sup id="cite_ref-pmid8652811_37-0" class="reference"><a href="#cite_note-pmid8652811-37"><span>[</span>37<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Chemotherapy">Chemotherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=13" title="Edit section: Chemotherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Combination <a href="/wiki/Chemotherapy_regimen" title="Chemotherapy regimen">chemotherapy regimens</a> are effective in both newly diagnosed and relapsed CLL. Combinations of fludarabine with alkylating agents (cyclophosphamide) produce higher response rates and a longer progression-free survival than single agents:</p>
<ul>
<li><b>FC</b> (<a href="/wiki/Fludarabine" title="Fludarabine">fludarabine</a> with <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>)<sup id="cite_ref-pmid16219797_38-0" class="reference"><a href="#cite_note-pmid16219797-38"><span>[</span>38<span>]</span></a></sup></li>
<li><b>FR</b> (<a href="/wiki/Fludarabine" title="Fludarabine">fludarabine</a> with <a href="/wiki/Rituximab" title="Rituximab">rituximab</a>)<sup id="cite_ref-pmid12393429_39-0" class="reference"><a href="#cite_note-pmid12393429-39"><span>[</span>39<span>]</span></a></sup></li>
<li><b>FCR</b> (<a href="/wiki/Fludarabine" title="Fludarabine">fludarabine</a>, <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, and <a href="/wiki/Rituximab" title="Rituximab">rituximab</a>)<sup id="cite_ref-pmid15767648_40-0" class="reference"><a href="#cite_note-pmid15767648-40"><span>[</span>40<span>]</span></a></sup></li>
<li><b>CHOP</b> (<a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, <a href="/wiki/Doxorubicin" title="Doxorubicin">doxorubicin</a>, <a href="/wiki/Vincristine" title="Vincristine">vincristine</a> and <a href="/wiki/Prednisolone" title="Prednisolone">prednisolone</a>)</li>
</ul>
<p>Although the purine analogue <a href="/wiki/Fludarabine" title="Fludarabine">fludarabine</a> was shown to give superior response rates to <a href="/wiki/Chlorambucil" title="Chlorambucil">chlorambucil</a> as primary therapy,<sup id="cite_ref-pmid11114313_41-0" class="reference"><a href="#cite_note-pmid11114313-41"><span>[</span>41<span>]</span></a></sup><sup id="cite_ref-pmid16856041_42-0" class="reference"><a href="#cite_note-pmid16856041-42"><span>[</span>42<span>]</span></a></sup> there is no evidence early use of fludarabine improves overall survival, and some clinicians prefer to reserve fludarabine for relapsed disease.</p>
<p>Chemoimmunotherapy with FCR has shown to improve response rates, progression-free survival and overall survival in a large randomized trial in CLL patients selected for good physical fitness.<sup id="cite_ref-pmid20888994_43-0" class="reference"><a href="#cite_note-pmid20888994-43"><span>[</span>43<span>]</span></a></sup> This has been the first clinical trial demonstrating that the choice of a first line therapy can improve the overall survival of patients with CLL.</p>
<p><a href="/wiki/Alkylating_agent" title="Alkylating agent" class="mw-redirect">Alkylating agents</a> approved for CLL include <a href="/wiki/Bendamustine" title="Bendamustine">bendamustine</a> and <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>.</p>
<h3><span class="mw-headline" id="Targeted_therapy">Targeted therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=14" title="Edit section: Targeted therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Targeted_therapy" title="Targeted therapy">Targeted therapy</a> attacks cancer cells at a specific target, with the aim of not harming normal cells.</p>
<p><a href="/wiki/Monoclonal_antibodies" title="Monoclonal antibodies" class="mw-redirect">Monoclonal antibodies</a>, such as <a href="/wiki/Alemtuzumab" title="Alemtuzumab">alemtuzumab</a> (directed against <a href="/wiki/CD52" title="CD52">CD52</a>), and <a href="/wiki/Rituximab" title="Rituximab">rituximab</a> and <a href="/wiki/Ofatumumab" title="Ofatumumab">ofatumumab</a> (directed against <a href="/wiki/CD20" title="CD20">CD20</a>), are used in CLL.<sup id="cite_ref-CTO_35-2" class="reference"><a href="#cite_note-CTO-35"><span>[</span>35<span>]</span></a></sup></p>
<p>Tyrosine kinase inhibitor therapy can also be used in CLL.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></p>
<p>In February 2014, the FDA granted <a href="/wiki/Ibrutinib" title="Ibrutinib">ibrutinib</a> approval to treat chronic lymphocytic leukemia. <a href="/wiki/Ibrutinib" title="Ibrutinib">Ibrutinib</a> is a <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton's tyrosine kinase">Bruton's tyrosine kinase</a> (BTK) inhibitor.</p>
<p>In July 2014, the FDA and EMA granted <a href="/wiki/Idelalisib" title="Idelalisib">idelalisib</a> approval to treat different types of leukemia.<sup id="cite_ref-FDA6387_45-0" class="reference"><a href="#cite_note-FDA6387-45"><span>[</span>45<span>]</span></a></sup> Idelalisib is a <a href="/wiki/PI3K" title="PI3K" class="mw-redirect">PI3K</a> inhibitor that targets the PI3Kδ pathway.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup> It is taken orally.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Stem_cell_transplantation">Stem cell transplantation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=15" title="Edit section: Stem cell transplantation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Autologous_stem_cell_transplantation" title="Autologous stem cell transplantation">Autologous stem cell transplantation</a>, using the recipient's own cells, is not curative.<sup id="cite_ref-Williams_2010_8_3-1" class="reference"><a href="#cite_note-Williams_2010_8-3"><span>[</span>3<span>]</span></a></sup><sup class="reference" style="white-space:nowrap;">:1458</sup> Younger individuals, if at high risk for dying from CLL, may consider <a href="/wiki/Allogeneic" title="Allogeneic" class="mw-redirect">allogeneic</a> <a href="/wiki/Hematopoietic_stem_cell_transplantation" title="Hematopoietic stem cell transplantation">hematopoietic stem cell transplantation</a> (HSCT). Myeloablative (bone marrow killing) forms of <a href="/wiki/Allogeneic_stem_cell_transplantation" title="Allogeneic stem cell transplantation" class="mw-redirect">allogeneic stem cell transplantation</a>, a high-risk treatment using blood cells from a healthy donor, may be curative, but treatment-related toxicity is significant.<sup id="cite_ref-Williams_2010_8_3-2" class="reference"><a href="#cite_note-Williams_2010_8-3"><span>[</span>3<span>]</span></a></sup><sup class="reference" style="white-space:nowrap;">:1458</sup> An intermediate level, called <i>reduced-intensity conditioning allogeneic stem cell transplantation</i>, may be better tolerated by older or frail patients.<sup id="cite_ref-pmid19147079_49-0" class="reference"><a href="#cite_note-pmid19147079-49"><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-Dreger_50-0" class="reference"><a href="#cite_note-Dreger-50"><span>[</span>50<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Refractory_CLL">Refractory CLL</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=16" title="Edit section: Refractory CLL">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>"Refractory" CLL is a disease that no longer responds favorably to treatment. In this case more aggressive therapies, including <a href="/wiki/Lenalidomide" title="Lenalidomide">lenalidomide</a>, <a href="/wiki/Flavopiridol" title="Flavopiridol" class="mw-redirect">flavopiridol</a>, and bone marrow (stem cell) transplantation, are considered.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup> The monoclonal antibody <a href="/wiki/Alemtuzumab" title="Alemtuzumab">alemtuzumab</a> (directed against <a href="/wiki/CD52" title="CD52">CD52</a>) may be used in patients with refractory, bone marrow-based disease.<sup id="cite_ref-Keating_52-0" class="reference"><a href="#cite_note-Keating-52"><span>[</span>52<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Complications">Complications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=17" title="Edit section: Complications">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Complications include <a href="/wiki/Richter%27s_syndrome" title="Richter's syndrome" class="mw-redirect">Richter's syndrome</a>, hypogammaglobulinemia leading to recurrent infection, <a href="/wiki/Warm_autoimmune_hemolytic_anemia" title="Warm autoimmune hemolytic anemia">warm autoimmune hemolytic anemia</a> in 10–15% of patients, transformation to high grade lymphoma.</p>
<p>Chronic lymphocytic leukemia may transform into <a href="/wiki/Richter%27s_syndrome" title="Richter's syndrome" class="mw-redirect">Richter's syndrome</a>, the development of fast-growing <a href="/wiki/Diffuse_large_B_cell_lymphoma" title="Diffuse large B cell lymphoma" class="mw-redirect">diffuse large B cell lymphoma</a>, <a href="/wiki/B-cell_prolymphocytic_leukemia" title="B-cell prolymphocytic leukemia">prolymphocytic leukemia</a>, <a href="/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Hodgkin's lymphoma</a>, or <a href="/wiki/Acute_leukemia" title="Acute leukemia">acute leukemia</a> in a patient who has chronic lymphocytic leukemia. Its incidence is estimated to be around 5 percent in patients with CLL.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup></p>
<p>Gastrointestinal (GI) involvement can rarely occur with chronic lymphocytic leukemia. Some of the reported manifestations include <a href="/wiki/Intussusception_(medical_disorder)" title="Intussusception (medical disorder)">intussusception</a>, small intestinal bacterial contamination, colitis and others. Usually, GI complications with CLL occur after Richter transformation. There have been two case reports to date of GI involvement in chronic lymphocytic leukemia without Richter's transformation.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=18" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>CLL is primarily a disease of older adults, with a median age of 70 years at the time of diagnosis.<sup id="cite_ref-Review_Shansai_55-0" class="reference"><a href="#cite_note-Review_Shansai-55"><span>[</span>55<span>]</span></a></sup> Though less common, CLL sometimes affects people between 30 and 39 years of age. The incidence of CLL increases very quickly with increasing age.</p>
<p>In the <a href="/wiki/United_States" title="United States">United States</a> during 2014, about 15,720 new cases are expected to be diagnosed, and 4,600 patients are expected to die from CLL.<sup id="cite_ref-Cancer_Gov_General_56-0" class="reference"><a href="#cite_note-Cancer_Gov_General-56"><span>[</span>56<span>]</span></a></sup> Because of the prolonged survival, which was typically about ten years in past decades, but which can extend to a normal life expectancy,<sup id="cite_ref-NCI-CLL-page2_10-2" class="reference"><a href="#cite_note-NCI-CLL-page2-10"><span>[</span>10<span>]</span></a></sup> the <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> (number of people living with the disease) is much higher than the <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> (new diagnoses). CLL is the most common type of leukemia in the UK, accounting for 38% of all leukemia cases. Around 3,200 people were diagnosed with the disease in 2011.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup></p>
<p>In Western populations, subclinical "disease" can be identified in 3.5% of normal adults,<sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup> and in up to 8% of individuals over the age of 70<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2008)">citation needed</span></a></i>]</sup>. That is, small clones of B cells with the characteristic CLL phenotype can be identified in many healthy elderly persons. The clinical significance of these cells is unknown.</p>
<p>In contrast, CLL is rare in Asian countries, such as Japan, China and Korea, accounting for less than 10 percent of all leukemias in those regions.<sup id="cite_ref-Review_Shansai_55-1" class="reference"><a href="#cite_note-Review_Shansai-55"><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-Williams_2010_8_3-3" class="reference"><a href="#cite_note-Williams_2010_8-3"><span>[</span>3<span>]</span></a></sup><sup class="reference" style="white-space:nowrap;">:1432</sup> A low incidence is seen in Japanese immigrants to the US, and in African and Asian immigrants to Israel.<sup id="cite_ref-Williams_2010_8_3-4" class="reference"><a href="#cite_note-Williams_2010_8-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Of all <a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">cancers involving the same class of blood cell</a>, 7% of cases are CLL/SLL.<sup id="cite_ref-isbn0-7817-5007-5_59-0" class="reference"><a href="#cite_note-isbn0-7817-5007-5-59"><span>[</span>59<span>]</span></a></sup></p>
<p>Rates of CLL are somewhat elevated in people exposed to certain chemicals. Under U.S. Department of Veterans' Affairs regulations, Vietnam veterans who served in-country or in the inland waterways of Vietnam and who later develop CLL are presumed to have contracted it from exposure to <a href="/wiki/Agent_Orange" title="Agent Orange">Agent Orange</a> and may be entitled to compensation.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=19" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Prognosis depends on the subtype. Some subtypes have a median survival of 6–8 years, while others have a median survival of 22 years (which is a normal lifespan for older patients).<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2013)">citation needed</span></a></i>]</sup> Telomere length has been suggested to be a valuable prognostic indicator of survival.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research_directions">Research directions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=20" title="Edit section: Research directions">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Current research is comparing different forms of bone marrow transplants to determine which patients are the best candidates and which approach is best in different situations.<sup id="cite_ref-pmid19147079_49-1" class="reference"><a href="#cite_note-pmid19147079-49"><span>[</span>49<span>]</span></a></sup></p>
<table class="mbox-small plainlinks sistersitebox" style="border:1px solid #aaa;background-color:#f9f9f9">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/40px-Wikinews-logo.svg.png" width="40" height="22" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/60px-Wikinews-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/80px-Wikinews-logo.svg.png 2x" data-file-width="759" data-file-height="415" /></td>
<td class="mbox-text plainlist">Wikinews has related news: <i><b><a href="//en.wikinews.org/wiki/Scientists_use_gene_therapy,_patients%27_own_immune_systems_to_fight_leukemia" class="extiw" title="wikinews:Scientists use gene therapy, patients' own immune systems to fight leukemia">Scientists use gene therapy, patients' own immune systems to fight leukemia</a></b></i></td>
</tr>
</table>
<p>Researchers at the Abramson Cancer Center of the <a href="/wiki/University_of_Pennsylvania_School_of_Medicine" title="University of Pennsylvania School of Medicine" class="mw-redirect">University of Pennsylvania School of Medicine</a> reported preliminary success in the use of <a href="/wiki/Gene_therapy" title="Gene therapy">gene therapy</a>, through genetically modified <a href="/wiki/T_cell" title="T cell">T cells</a>, to treat CLL.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup> The findings, which were published in August 2011,<sup id="cite_ref-NEJ_63-0" class="reference"><a href="#cite_note-NEJ-63"><span>[</span>63<span>]</span></a></sup><sup id="cite_ref-STM_64-0" class="reference"><a href="#cite_note-STM-64"><span>[</span>64<span>]</span></a></sup> were based on data from three patients who had modified T cells injected into their blood. The T cells had been modified to express genes that would allow the cells to proliferate in the body and destroy B cells including those causing the leukemia. Two patients went into <a href="/wiki/Partial_remission" title="Partial remission" class="mw-redirect">remission</a>, while the presence of leukemia in the third patient reduced by 70 percent.<sup id="cite_ref-NPR_65-0" class="reference"><a href="#cite_note-NPR-65"><span>[</span>65<span>]</span></a></sup><sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>66<span>]</span></a></sup> One of the patients had been diagnosed with CLL for 13 years, and his treatment was failing before he participated in the clinical trial. One week after the T cells were injected, the leukemia cells in his blood had disappeared.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup> The T cells were still found in the bloodstream of the patients six months after the procedure, meaning they would be able to fight the disease should leukemia cells return.<sup id="cite_ref-NPR_65-1" class="reference"><a href="#cite_note-NPR-65"><span>[</span>65<span>]</span></a></sup> This was the first time scientists "have used gene therapy to successfully destroy cancer tumors in patients with advanced disease".<sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span>[</span>68<span>]</span></a></sup> One editorial in <i><a href="/wiki/The_New_England_Journal_of_Medicine" title="The New England Journal of Medicine">The New England Journal of Medicine</a></i> also urged caution because only more trials would indicate whether the findings are "an authentic advance toward a clinically applicable and effective therapy".<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup><sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup></p>
<p>Research is also investigating therapies targeting <a href="/wiki/B_cell_receptor" title="B cell receptor" class="mw-redirect">B cell receptor</a> signalling. <a href="/wiki/Syk" title="Syk">Syk</a> inhibitor <a href="/wiki/Fostamatinib" title="Fostamatinib">Fostamatinib</a> is in trials.<sup id="cite_ref-pmid25050922_71-0" class="reference"><a href="#cite_note-pmid25050922-71"><span>[</span>71<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=21" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Monoclonal_B-cell_lymphocytosis" title="Monoclonal B-cell lymphocytosis">Monoclonal B-cell lymphocytosis</a></li>
<li><a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">Virtual Karyotype</a></li>
<li><a href="/wiki/B-cell_CLL/lymphoma" title="B-cell CLL/lymphoma">B-cell CLL/lymphoma</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=22" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><span class="citation web">Byrd, John. <a rel="nofollow" class="external text" href="http://www.lls.org/#/diseaseinformation/leukemia/chroniclymphocyticleukemia/">"Chronic Lymphocytic Leukemia"</a>. <i>Leukemia &amp; Lymphoma Society</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 March</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Chronic+Lymphocytic+Leukemia&amp;rft.au=Byrd%2C+John&amp;rft.aufirst=John&amp;rft.aulast=Byrd&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.lls.org%2F%23%2Fdiseaseinformation%2Fleukemia%2Fchroniclymphocyticleukemia%2F&amp;rft.jtitle=Leukemia+%26+Lymphoma+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10577857-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10577857_2-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999). "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997". <i>J. Clin. Oncol.</i> <b>17</b> (12): 3835–49. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10577857">10577857</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=World+Health+Organization+classification+of+neoplastic+diseases+of+the+hematopoietic+and+lymphoid+tissues%3A+report+of+the+Clinical+Advisory+Committee+meeting-Airlie+House%2C+Virginia%2C+November+1997&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F10577857&amp;rft.issue=12&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=3835-49&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Williams_2010_8-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Williams_2010_8_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Williams_2010_8_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Williams_2010_8_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Williams_2010_8_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Williams_2010_8_3-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Kaushansky, K; Lichtman, M; Beutler, E; Kipps, T; Prchal, J; Seligsohn, U. (2010). <i>Williams Hematology</i> (8th ed.). McGraw-Hill. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0071621519" title="Special:BookSources/978-0071621519">978-0071621519</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.au=Beutler%2C+E&amp;rft.aufirst=K&amp;rft.au=Kaushansky%2C+K&amp;rft.au=Kipps%2C+T&amp;rft.aulast=Kaushansky&amp;rft.au=Lichtman%2C+M&amp;rft.au=Prchal%2C+J&amp;rft.au=Seligsohn%2C+U.&amp;rft.btitle=Williams+Hematology&amp;rft.date=2010&amp;rft.edition=8th&amp;rft.genre=book&amp;rft.isbn=978-0071621519&amp;rft.pub=McGraw-Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15728813-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15728813_4-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Chiorazzi N, Rai KR, Ferrarini M (2005). "Chronic lymphocytic leukemia". <i>N. Engl. J. Med.</i> <b>352</b> (8): 804–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra041720">10.1056/NEJMra041720</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15728813">15728813</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Chronic+lymphocytic+leukemia&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra041720&amp;rft_id=info%3Apmid%2F15728813&amp;rft.issue=8&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=804-15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=352" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn1-4051-4265-0-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn1-4051-4265-0_5-0">^</a></b></span> <span class="reference-text"><span class="citation book">Bain, Barbara J. (2006). <i>Blood Cells: A Practical Guide</i>. Blackwell Publishing Limited. p.&#160;439. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4051-4265-0" title="Special:BookSources/1-4051-4265-0">1-4051-4265-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.au=Bain%2C+Barbara+J.&amp;rft.aulast=Bain%2C+Barbara+J.&amp;rft.btitle=Blood+Cells%3A+A+Practical+Guide&amp;rft.date=2006&amp;rft.genre=book&amp;rft.isbn=1-4051-4265-0&amp;rft.pages=439&amp;rft.pub=Blackwell+Publishing+Limited&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid7523797-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7523797_6-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D (1994). "The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL". <i>Leukemia</i> <b>8</b> (10): 1640–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7523797">7523797</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=The+immunological+profile+of+B-cell+disorders+and+proposal+of+a+scoring+system+for+the+diagnosis+of+CLL&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F7523797&amp;rft.issue=10&amp;rft.jtitle=Leukemia&amp;rft.pages=1640-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CD54-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-CD54_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Deans JP, Polyak MJ (2008). "FMC7 is an epitope of CD20". <i>Blood</i> <b>111</b> (4): 2492; author reply 2493–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2007-11-126243">10.1182/blood-2007-11-126243</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18263793">18263793</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=FMC7+is+an+epitope+of+CD20&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-11-126243&amp;rft_id=info%3Apmid%2F18263793&amp;rft.issue=4&amp;rft.jtitle=Blood&amp;rft.pages=2492%3B+author+reply+2493-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=111" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CD200-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-CD200_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, Conticello C, Villari L, Di Raimondo F (2009). "CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia". <i>Leuk. Res.</i> <b>33</b> (9): 1212–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.leukres.2009.01.017">10.1016/j.leukres.2009.01.017</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19230971">19230971</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=CD200+expression+may+help+in+differential+diagnosis+between+mantle+cell+lymphoma+and+B-cell+chronic+lymphocytic+leukemia&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.leukres.2009.01.017&amp;rft_id=info%3Apmid%2F19230971&amp;rft.issue=9&amp;rft.jtitle=Leuk.+Res.&amp;rft.pages=1212-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MCL-CLL-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-MCL-CLL_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zare H, Bashashati A, Kridel R, Aghaeepour N, Haffari G, Connors JM, Gascoyne RD, Gupta A, Brinkman RR, Weng AP (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4090220">"Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma"</a>. <i>Am. J. Clin. Pathol.</i> <b>137</b> (1): 75–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1309%2FAJCPMMLQ67YOMGEW">10.1309/AJCPMMLQ67YOMGEW</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4090220">4090220</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22180480">22180480</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Automated+analysis+of+multidimensional+flow+cytometry+data+improves+diagnostic+accuracy+between+mantle+cell+lymphoma+and+small+lymphocytic+lymphoma&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4090220&amp;rft_id=info%3Adoi%2F10.1309%2FAJCPMMLQ67YOMGEW&amp;rft_id=info%3Apmc%2F4090220&amp;rft_id=info%3Apmid%2F22180480&amp;rft.issue=1&amp;rft.jtitle=Am.+J.+Clin.+Pathol.&amp;rft.pages=75-85&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=137" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NCI-CLL-page2-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCI-CLL-page2_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCI-CLL-page2_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCI-CLL-page2_10-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web">National Cancer Institute. <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/CLL/HealthProfessional/page2">"Chronic Lymphocytic Leukemia (PDQ) Treatment: Stage Information"</a>. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071017143320/http://www.cancer.gov/cancertopics/pdq/treatment/CLL/HealthProfessional/page2">Archived</a> from the original on 17 October 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-09-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.aulast=National+Cancer+Institute&amp;rft.au=National+Cancer+Institute&amp;rft.btitle=Chronic+Lymphocytic+Leukemia+%28PDQ%29+Treatment%3A+Stage+Information&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2FCLL%2FHealthProfessional%2Fpage2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation book">Gale, Robert Peter; Rai, Kanti R., eds. (1987). <i>Chronic lymphocytic leukemia&#160;: recent progress, future direction&#160;: proceedings of a Hyland Laboratories-UCLA symposium held in Napa, California, December 2-5, 1986</i>. New York: Liss. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780845126585" title="Special:BookSources/9780845126585">9780845126585</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.btitle=Chronic+lymphocytic+leukemia+%3A+recent+progress%2C+future+direction+%3A+proceedings+of+a+Hyland+Laboratories-UCLA+symposium+held+in+Napa%2C+California%2C+December+2-5%2C+1986&amp;rft.date=1987&amp;rft.genre=book&amp;rft.isbn=9780845126585&amp;rft.place=New+York&amp;rft.pub=Liss&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (Aug 1975). "Clinical staging of chronic lymphocytic leukemia.". <i>Blood</i> <b>46</b> (2): 219–34. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1139039">1139039</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Clinical+staging+of+chronic+lymphocytic+leukemia.&amp;rft.date=Aug+1975&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1139039&amp;rft.issue=2&amp;rft.jtitle=Blood&amp;rft.pages=219-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F (Jul 1, 1981). "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.". <i>Cancer</i> <b>48</b> (1): 198–206. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F1097-0142%2819810701%2948%3A1%3C198%3A%3Aaid-cncr2820480131%3E3.0.co%3B2-v">10.1002/1097-0142(19810701)48:1&lt;198::aid-cncr2820480131&gt;3.0.co;2-v</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7237385">7237385</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=A+new+prognostic+classification+of+chronic+lymphocytic+leukemia+derived+from+a+multivariate+survival+analysis.&amp;rft.date=Jul+1%2C+1981&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%2819810701%2948%3A1%3C198%3A%3Aaid-cncr2820480131%3E3.0.co%3B2-v&amp;rft_id=info%3Apmid%2F7237385&amp;rft.issue=1&amp;rft.jtitle=Cancer&amp;rft.pages=198-206&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11733578-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11733578_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM (2001). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2193523">"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia"</a>. <i>J. Exp. Med.</i> <b>194</b> (11): 1639–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1084%2Fjem.194.11.1639">10.1084/jem.194.11.1639</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2193523">2193523</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11733578">11733578</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Relation+of+gene+expression+phenotype+to+immunoglobulin+mutation+genotype+in+B+cell+chronic+lymphocytic+leukemia&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2193523&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.194.11.1639&amp;rft_id=info%3Apmc%2F2193523&amp;rft_id=info%3Apmid%2F11733578&amp;rft.issue=11&amp;rft.jtitle=J.+Exp.+Med.&amp;rft.pages=1639-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=194" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12406914-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12406914_15-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ghia P, Guida G, Stella S, Gottardi D, Geuna M, Strola G, Scielzo C, Caligaris-Cappio F (2003). "The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression". <i>Blood</i> <b>101</b> (4): 1262–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2002-06-1801">10.1182/blood-2002-06-1801</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12406914">12406914</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=The+pattern+of+CD38+expression+defines+a+distinct+subset+of+chronic+lymphocytic+leukemia+%28CLL%29+patients+at+risk+of+disease+progression&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2002-06-1801&amp;rft_id=info%3Apmid%2F12406914&amp;rft.issue=4&amp;rft.jtitle=Blood&amp;rft.pages=1262-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16983131-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16983131_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16983131_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid16983131_16-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE (2006). <a rel="nofollow" class="external text" href="http://www.annals.org/cgi/content/full/145/6/435">"Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia"</a>. <i>Ann. Intern. Med.</i> <b>145</b> (6): 435–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-145-6-200609190-00007">10.7326/0003-4819-145-6-200609190-00007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16983131">16983131</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Narrative+review%3A+initial+management+of+newly+diagnosed%2C+early-stage+chronic+lymphocytic+leukemia&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.annals.org%2Fcgi%2Fcontent%2Ffull%2F145%2F6%2F435&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-6-200609190-00007&amp;rft_id=info%3Apmid%2F16983131&amp;rft.issue=6&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=435-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=145" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10477713-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10477713_17-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999). <a rel="nofollow" class="external text" href="http://bloodjournal.hematologylibrary.org/cgi/content/full/94/6/1848">"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia"</a>. <i>Blood</i> <b>94</b> (6): 1848–54. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10477713">10477713</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Unmutated+Ig+V%28H%29+genes+are+associated+with+a+more+aggressive+form+of+chronic+lymphocytic+leukemia&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Ffull%2F94%2F6%2F1848&amp;rft_id=info%3Apmid%2F10477713&amp;rft.issue=6&amp;rft.jtitle=Blood&amp;rft.pages=1848-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=94" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Tobin G, Thunberg U, Johnson A, Thörn I, Söderberg O, Hultdin M, Botling J, Enblad G, Sällström J, Sundström C, Roos G, Rosenquist R (2002). "Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia". <i>Blood</i> <b>99</b> (6): 2262–2264. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood.V99.6.2262">10.1182/blood.V99.6.2262</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11877310">11877310</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Somatically+mutated+Ig+V%28H%293-21+genes+characterize+a+new+subset+of+chronic+lymphocytic+leukemia&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V99.6.2262&amp;rft_id=info%3Apmid%2F11877310&amp;rft.issue=6&amp;rft.jtitle=Blood&amp;rft.pages=2262-2264&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=99" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Mraz M, Dolezalova D, Plevova K, Stano Kozubik K, Mayerova V, Cerna K, Musilova K, Tichy B, Pavlova S, Borsky M, Verner J, Doubek M, Brychtova Y, Trbusek M, Hampl A, Mayer J, Pospisilova S (2012). "MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia". <i>Blood</i> <b>119</b> (9): 2110–2113. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2011-11-394874">10.1182/blood-2011-11-394874</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22234685">22234685</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=MicroRNA-650+expression+is+influenced+by+immunoglobulin+gene+rearrangement+and+affects+the+biology+of+chronic+lymphocytic+leukemia&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2011-11-394874&amp;rft_id=info%3Apmid%2F22234685&amp;rft.issue=9&amp;rft.jtitle=Blood&amp;rft.pages=2110-2113&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=119" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11136261-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11136261_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P (2000). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/343/26/1910">"Genomic aberrations and survival in chronic lymphocytic leukemia"</a>. <i>NEJM</i> <b>343</b> (26): 1910–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM200012283432602">10.1056/NEJM200012283432602</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11136261">11136261</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Genomic+aberrations+and+survival+in+chronic+lymphocytic+leukemia&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F343%2F26%2F1910&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM200012283432602&amp;rft_id=info%3Apmid%2F11136261&amp;rft.issue=26&amp;rft.jtitle=NEJM&amp;rft.pages=1910-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=343" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B, Malcikova J, Stano Kozubik K, Smardova J, Brychtova Y, Doubek M, Trbusek M, Mayer J, Pospisilova S (2009). "MiR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities". <i>Leukemia</i> <b>23</b> (6): 1159–1163. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fleu.2008.377">10.1038/leu.2008.377</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19158830">19158830</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=MiR-34a%2C+miR-29c+and+miR-17-5p+are+downregulated+in+CLL+patients+with+TP53+abnormalities&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fleu.2008.377&amp;rft_id=info%3Apmid%2F19158830&amp;rft.issue=6&amp;rft.jtitle=Leukemia&amp;rft.pages=1159-1163&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><span class="citation journal">Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J (2009). "MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes". <i>Leukemia &amp; Lymphoma</i> <b>50</b> (3): 506–509. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F10428190902763517">10.1080/10428190902763517</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19347736">19347736</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=MicroRNAs+in+chronic+lymphocytic+leukemia+pathogenesis+and+disease+subtypes&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F10428190902763517&amp;rft_id=info%3Apmid%2F19347736&amp;rft.issue=3&amp;rft.jtitle=Leukemia+%26+Lymphoma&amp;rft.pages=506-509&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Mraz M, Pospisilova S (2012). "MicroRNAs in chronic lymphocytic leukemia: From causality to associations and back". <i>Expert Review of Hematology</i> <b>5</b> (6): 579–581. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1586%2Fehm.12.54">10.1586/ehm.12.54</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23216588">23216588</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=MicroRNAs+in+chronic+lymphocytic+leukemia%3A+From+causality+to+associations+and+back&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1586%2Fehm.12.54&amp;rft_id=info%3Apmid%2F23216588&amp;rft.issue=6&amp;rft.jtitle=Expert+Review+of+Hematology&amp;rft.pages=579-581&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18931683-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18931683_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R (2008). "The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.". <i>Nat Med</i> <b>14</b> (11): 1271–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnm.1880">10.1038/nm.1880</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18931683">18931683</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=The+miR-15a-miR-16-1+cluster+controls+prostate+cancer+by+targeting+multiple+oncogenic+activities.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.1880&amp;rft_id=info%3Apmid%2F18931683&amp;rft.issue=11&amp;rft.jtitle=Nat+Med&amp;rft.pages=1271-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Musilova K, Mraz M (2014). "MicroRNAs in B cell lymphomas: How a complex biology gets more complex". <i>Leukemia</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fleu.2014.351">10.1038/leu.2014.351</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25541152">25541152</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=MicroRNAs+in+B+cell+lymphomas%3A+How+a+complex+biology+gets+more+complex&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fleu.2014.351&amp;rft_id=info%3Apmid%2F25541152&amp;rft.jtitle=Leukemia&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, Bastard C, Kawamata N, Koeffler HP (March 2008). "Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia". <i>Cancer</i> <b>112</b> (6): 1296–305. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.23270">10.1002/cncr.23270</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18246537">18246537</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Molecular+allelokaryotyping+of+early-stage%2C+untreated+chronic+lymphocytic+leukemia&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.23270&amp;rft_id=info%3Apmid%2F18246537&amp;rft.issue=6&amp;rft.jtitle=Cancer&amp;rft.pages=1296-305&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=112" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, Wierda WG, Keating MJ, Luthra R (January 2009). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S1525-1578(10)60205-X">"Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia"</a>. <i>J Mol Diagn</i> <b>11</b> (1): 25–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2353%2Fjmoldx.2009.080037">10.2353/jmoldx.2009.080037</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2607562">2607562</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19074592">19074592</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Customized+oligonucleotide+array-based+comparative+genomic+hybridization+as+a+clinical+assay+for+genomic+profiling+of+chronic+lymphocytic+leukemia&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1525-1578%2810%2960205-X&amp;rft_id=info%3Adoi%2F10.2353%2Fjmoldx.2009.080037&amp;rft_id=info%3Apmc%2F2607562&amp;rft_id=info%3Apmid%2F19074592&amp;rft.issue=1&amp;rft.jtitle=J+Mol+Diagn&amp;rft.pages=25-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Döhner H, Bentz M, Lichter P (January 2004). <a rel="nofollow" class="external text" href="http://www.pnas.org/cgi/pmidlookup?view=long&amp;pmid=14730057">"Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>101</b> (4): 1039–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.0304717101">10.1073/pnas.0304717101</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC327147">327147</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14730057">14730057</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Automated+array-based+genomic+profiling+in+chronic+lymphocytic+leukemia%3A+development+of+a+clinical+tool+and+discovery+of+recurrent+genomic+alterations&amp;rft.date=January+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D14730057&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0304717101&amp;rft_id=info%3Apmc%2F327147&amp;rft_id=info%3Apmid%2F14730057&amp;rft.issue=4&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=1039-44&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, Fisch P, Timmer J, Veelken H (February 2007). <a rel="nofollow" class="external text" href="http://www.bloodjournal.org/cgi/pmidlookup?view=long&amp;pmid=17053054">"Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays"</a>. <i>Blood</i> <b>109</b> (3): 1202–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2006-07-034256">10.1182/blood-2006-07-034256</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17053054">17053054</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Genome-wide+analysis+of+DNA+copy+number+changes+and+LOH+in+CLL+using+high-density+SNP+arrays&amp;rft.date=February+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloodjournal.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D17053054&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2006-07-034256&amp;rft_id=info%3Apmid%2F17053054&amp;rft.issue=3&amp;rft.jtitle=Blood&amp;rft.pages=1202-10&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=109" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, Preobrazhensky SN, Higgins RA, Bolla AR, Ismail SH, de Jong D, Eldering E, van Oers MH, Mellink CH, Keating MJ, Schlette EJ, Abruzzo LV, Robetorye RS (September 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518739">"Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia"</a>. <i>J Mol Diagn</i> <b>10</b> (5): 442–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2353%2Fjmoldx.2008.080033">10.2353/jmoldx.2008.080033</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518739">2518739</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18687794">18687794</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Whole-genome+scanning+by+array+comparative+genomic+hybridization+as+a+clinical+tool+for+risk+assessment+in+chronic+lymphocytic+leukemia&amp;rft.date=September+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2518739&amp;rft_id=info%3Adoi%2F10.2353%2Fjmoldx.2008.080033&amp;rft_id=info%3Apmc%2F2518739&amp;rft_id=info%3Apmid%2F18687794&amp;rft.issue=5&amp;rft.jtitle=J+Mol+Diagn&amp;rft.pages=442-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.accessmedicine.com/content.aspx?aid=2149838">"T Cell Prolymphocytic Leukemia"</a>. AccessMedicine<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-02-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.btitle=T+Cell+Prolymphocytic+Leukemia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.accessmedicine.com%2Fcontent.aspx%3Faid%3D2149838&amp;rft.pub=AccessMedicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10442186-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10442186_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ascani S, Leoni P, Fraternali Orcioni G, Bearzi I, Piccioli M, Materazzi M, Zinzani PL, Gherlinzoni F, Falini B, Pileri SA (June 1999). <a rel="nofollow" class="external text" href="http://annonc.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10442186">"T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature"</a>. <i>Ann. Oncol.</i> <b>10</b> (6): 649–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1023%2FA%3A1008349422735">10.1023/A:1008349422735</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10442186">10442186</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=T-cell+prolymphocytic+leukaemia%3A+does+the+expression+of+CD8%2B+phenotype+justify+the+identification+of+a+new+subtype%3F+Description+of+two+cases+and+review+of+the+literature&amp;rft.date=June+1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fannonc.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10442186&amp;rft_id=info%3Adoi%2F10.1023%2FA%3A1008349422735&amp;rft_id=info%3Apmid%2F10442186&amp;rft.issue=6&amp;rft.jtitle=Ann.+Oncol.&amp;rft.pages=649-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text">Harison 18th ed., Pg-919, table 110.1) th</span></li>
<li id="cite_note-PDQ-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-PDQ_34-0">^</a></b></span> <span class="reference-text"><span class="citation web">National Cancer Institute. <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/CLL/HealthProfessional/page5">"Chronic Lymphocytic Leukemia (PDQ) Treatment: Stage I, II, III, and IV Chronic Lymphocytic Leukemia"</a>. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071017143326/http://www.cancer.gov/cancertopics/pdq/treatment/CLL/HealthProfessional/page5">Archived</a> from the original on 17 October 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-09-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.aulast=National+Cancer+Institute&amp;rft.au=National+Cancer+Institute&amp;rft.btitle=Chronic+Lymphocytic+Leukemia+%28PDQ%29+Treatment%3A+Stage+I%2C+II%2C+III%2C+and+IV+Chronic+Lymphocytic+Leukemia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2FCLL%2FHealthProfessional%2Fpage5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CTO-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-CTO_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CTO_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CTO_35-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Janssens et al. (2011). <a rel="nofollow" class="external text" href="http://www.onclive.com/publications/contemporary-oncology/2011/fall-2011/Rituximab-for-Chronic-Lymphocytic-Leukemia-in-Treatment-Nave-and-Treatment-Experienced-Patients">"Rituximab for Chronic Lymphocytic Leukemia in Treatment-Naïve and Treatment-Experienced Patients"</a>. <i>Contemporary Oncology</i> <b>3</b> (3): 24–36.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Rituximab+for+Chronic+Lymphocytic+Leukemia+in+Treatment-Na%C3%AFve+and+Treatment-Experienced+Patients&amp;rft.au=Janssens&amp;rft.aulast=Janssens&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.onclive.com%2Fpublications%2Fcontemporary-oncology%2F2011%2Ffall-2011%2FRituximab-for-Chronic-Lymphocytic-Leukemia-in-Treatment-Nave-and-Treatment-Experienced-Patients&amp;rft.issue=3&amp;rft.jtitle=Contemporary+Oncology&amp;rft.pages=24-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Shapira-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shapira_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shapira_36-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Shapira T, Pereg D, Lishner M (September 2008). "How I treat acute and chronic leukemia in pregnancy". <i>Blood Rev.</i> <b>22</b> (5): 247–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.blre.2008.03.006">10.1016/j.blre.2008.03.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18472198">18472198</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=How+I+treat+acute+and+chronic+leukemia+in+pregnancy&amp;rft.date=September+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.blre.2008.03.006&amp;rft_id=info%3Apmid%2F18472198&amp;rft.issue=5&amp;rft.jtitle=Blood+Rev.&amp;rft.pages=247-59&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8652811-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8652811_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR (1996). "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment". <i>Blood</i> <b>87</b> (12): 4990–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8652811">8652811</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=National+Cancer+Institute-sponsored+Working+Group+guidelines+for+chronic+lymphocytic+leukemia%3A+revised+guidelines+for+diagnosis+and+treatment&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8652811&amp;rft.issue=12&amp;rft.jtitle=Blood&amp;rft.pages=4990-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=87" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16219797-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16219797_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, Siehl S, Jäger U, Bergmann M, Stilgenbauer S, Schweighofer C, Wendtner CM, Döhner H, Brittinger G, Emmerich B, Hallek M (2006). "Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia". <i>Blood</i> <b>107</b> (3): 885–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2005-06-2395">10.1182/blood-2005-06-2395</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16219797">16219797</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Fludarabine+plus+cyclophosphamide+versus+fludarabine+alone+in+first-line+therapy+of+younger+patients+with+chronic+lymphocytic+leukemia&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2005-06-2395&amp;rft_id=info%3Apmid%2F16219797&amp;rft.issue=3&amp;rft.jtitle=Blood&amp;rft.pages=885-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=107" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12393429-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12393429_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Byrd JC, Peterson BL, Morrison VA, Park K, Jacobson R, Hoke E, Vardiman JW, Rai K, Schiffer CA, Larson RA (2003). "Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)". <i>Blood</i> <b>101</b> (1): 6–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2002-04-1258">10.1182/blood-2002-04-1258</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12393429">12393429</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Randomized+phase+2+study+of+fludarabine+with+concurrent+versus+sequential+treatment+with+rituximab+in+symptomatic%2C+untreated+patients+with+B-cell+chronic+lymphocytic+leukemia%3A+results+from+Cancer+and+Leukemia+Group+B+9712+%28CALGB+9712%29&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2002-04-1258&amp;rft_id=info%3Apmid%2F12393429&amp;rft.issue=1&amp;rft.jtitle=Blood&amp;rft.pages=6-14&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15767648-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15767648_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, Andreeff M, Cortes J, Faderl S, Thomas D, Koller C, Wierda W, Detry MA, Lynn A, Kantarjian H (2005). "Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia". <i>J. Clin. Oncol.</i> <b>23</b> (18): 4079–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2005.12.051">10.1200/JCO.2005.12.051</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15767648">15767648</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Early+results+of+a+chemoimmunotherapy+regimen+of+fludarabine%2C+cyclophosphamide%2C+and+rituximab+as+initial+therapy+for+chronic+lymphocytic+leukemia&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2005.12.051&amp;rft_id=info%3Apmid%2F15767648&amp;rft.issue=18&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=4079-88&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11114313-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11114313_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA (2000). "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia". <i>N. Engl. J. Med.</i> <b>343</b> (24): 1750–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM200012143432402">10.1056/NEJM200012143432402</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11114313">11114313</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Fludarabine+compared+with+chlorambucil+as+primary+therapy+for+chronic+lymphocytic+leukemia&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM200012143432402&amp;rft_id=info%3Apmid%2F11114313&amp;rft.issue=24&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1750-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=343" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16856041-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16856041_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R (2006). Steurer, Michael, ed. "Purine antagonists for chronic lymphocytic leukaemia". <i>Cochrane database of systematic reviews (Online)</i> <b>3</b> (3): CD004270. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD004270.pub2">10.1002/14651858.CD004270.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16856041">16856041</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Purine+antagonists+for+chronic+lymphocytic+leukaemia&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004270.pub2&amp;rft_id=info%3Apmid%2F16856041&amp;rft.issue=3&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD004270&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20888994-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20888994_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S (2010). "Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial". <i>Lancet</i> <b>376</b> (9747): 1164–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2810%2961381-5">10.1016/S0140-6736(10)61381-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20888994">20888994</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Addition+of+rituximab+to+fludarabine+and+cyclophosphamide+in+patients+with+chronic+lymphocytic+leukaemia%3A+a+randomised%2C+open-label%2C+phase+3+trial&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2810%2961381-5&amp;rft_id=info%3Apmid%2F20888994&amp;rft.issue=9747&amp;rft.jtitle=Lancet&amp;rft.pages=1164-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=376" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text">National Cancer Institute: rnChronic Lymphocytic Leukemia Treatment</span></li>
<li id="cite_note-FDA6387-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA6387_45-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm406387.htm">"FDA approves Zydelig for three types of blood cancers"</a>. Food and Drug Administration. July 23, 2014.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.btitle=FDA+approves+Zydelig+for+three+types+of+blood+cancers&amp;rft.date=July+23%2C+2014&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm406387.htm&amp;rft.pub=Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><span class="citation journal">"Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.". <i>Blood</i> <b>123</b> (22): 3390–7. May 2014. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2013-11-535047">10.1182/blood-2013-11-535047</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24615777">24615777</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Idelalisib%2C+an+inhibitor+of+phosphatidylinositol+3-kinase+p110%CE%B4%2C+for+relapsed%2Frefractory+chronic+lymphocytic+leukemia.&amp;rft.date=May+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2013-11-535047&amp;rft_id=info%3Apmid%2F24615777&amp;rft.issue=22&amp;rft.jtitle=Blood&amp;rft.pages=3390-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=123" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039496/">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039496/</a></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">"The biology behind PI3K inhibition in chronic lymphocytic leukaemia.". <i>Ther Adv Hematol</i> <b>6</b> (1): 25–36. Feb 2015. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1177%2F2040620714561581">10.1177/2040620714561581</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25642313">25642313</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=The+biology+behind+PI3K+inhibition+in+chronic+lymphocytic+leukaemia.&amp;rft.date=Feb+2015&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F2040620714561581&amp;rft_id=info%3Apmid%2F25642313&amp;rft.issue=1&amp;rft.jtitle=Ther+Adv+Hematol&amp;rft.pages=25-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19147079-49"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19147079_49-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19147079_49-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gribben JG (January 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2668540">"Stem cell transplantation in chronic lymphocytic leukemia"</a>. <i>Biol. Blood Marrow Transplant.</i> <b>15</b> (1 Suppl): 53–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.bbmt.2008.10.022">10.1016/j.bbmt.2008.10.022</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2668540">2668540</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19147079">19147079</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Stem+cell+transplantation+in+chronic+lymphocytic+leukemia&amp;rft.date=January+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2668540&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbmt.2008.10.022&amp;rft_id=info%3Apmc%2F2668540&amp;rft_id=info%3Apmid%2F19147079&amp;rft.issue=1+Suppl&amp;rft.jtitle=Biol.+Blood+Marrow+Transplant.&amp;rft.pages=53-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dreger-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dreger_50-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, Van Biezen A, Michallet M, Niederwieser D (2003). "Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning". <i>Leukemia</i> <b>17</b> (5): 841–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.leu.2402905">10.1038/sj.leu.2402905</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12750695">12750695</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Treatment-related+mortality+and+graft-versus-leukemia+activity+after+allogeneic+stem+cell+transplantation+for+chronic+lymphocytic+leukemia+using+intensity-reduced+conditioning&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.leu.2402905&amp;rft_id=info%3Apmid%2F12750695&amp;rft.issue=5&amp;rft.jtitle=Leukemia&amp;rft.pages=841-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation web">National Cancer Institute. <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/CLL/HealthProfessional/page6">"Chronic Lymphocytic Leukemia (PDQ) Treatment: Refractory Chronic Lymphocytic Leukemia"</a>. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071017143330/http://www.cancer.gov/cancertopics/pdq/treatment/CLL/HealthProfessional/page6">Archived</a> from the original on 17 October 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-09-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.aulast=National+Cancer+Institute&amp;rft.au=National+Cancer+Institute&amp;rft.btitle=Chronic+Lymphocytic+Leukemia+%28PDQ%29+Treatment%3A+Refractory+Chronic+Lymphocytic+Leukemia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2FCLL%2FHealthProfessional%2Fpage6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Keating-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Keating_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Keating MJ, Flinn I, Jain V, Binet JL, Hillmen P, Byrd J, Albitar M, Brettman L, Santabarbara P, Wacker B, Rai KR (2002). "Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study". <i>Blood</i> <b>99</b> (10): 3554–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood.V99.10.3554">10.1182/blood.V99.10.3554</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11986207">11986207</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Therapeutic+role+of+alemtuzumab+%28Campath-1H%29+in+patients+who+have+failed+fludarabine%3A+results+of+a+large+international+study&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V99.10.3554&amp;rft_id=info%3Apmid%2F11986207&amp;rft.issue=10&amp;rft.jtitle=Blood&amp;rft.pages=3554-61&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=99" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><span class="citation journal">Tsimberidou AM, Keating MJ (January 2005). "Richter syndrome: biology, incidence, and therapeutic strategies". <i>Cancer</i> <b>103</b> (2): 216–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.20773">10.1002/cncr.20773</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15578683">15578683</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Richter+syndrome%3A+biology%2C+incidence%2C+and+therapeutic+strategies&amp;rft.date=January+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.20773&amp;rft_id=info%3Apmid%2F15578683&amp;rft.issue=2&amp;rft.jtitle=Cancer&amp;rft.pages=216-28&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=103" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text">Bitetto AM, Lamba G, Cadavid G, Shah D, Forlenza T, Rotatori F, Rafiyath SM. Colonic perforation secondary to chronic lymphocytic leukemia infiltration without Richter transformation. Leuk Lymphoma. 2011 May;52(5):930-3.</span></li>
<li id="cite_note-Review_Shansai-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-Review_Shansai_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Review_Shansai_55-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Shanshal M, Haddad RY (April 2012). "Chronic Lymphocytic Leukemia". <i>Disease-a-Month</i> <b>58</b> (4): 153–167. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.disamonth.2012.01.009">10.1016/j.disamonth.2012.01.009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22449365">22449365</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Chronic+Lymphocytic+Leukemia&amp;rft.date=April+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.disamonth.2012.01.009&amp;rft_id=info%3Apmid%2F22449365&amp;rft.issue=4&amp;rft.jtitle=Disease-a-Month&amp;rft.pages=153-167&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment"><code style="color:inherit; border:inherit; padding:inherit;">|accessdate=</code> requires <code style="color:inherit; border:inherit; padding:inherit;">|url=</code> (<a href="/wiki/Help:CS1_errors#accessdate_missing_url" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Cancer_Gov_General-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cancer_Gov_General_56-0">^</a></b></span> <span class="reference-text"><span class="citation web">National Cancer Institute. <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/page1">"General Information About Chronic Lymphocytic Leukemia"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2007-09-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.aulast=National+Cancer+Institute&amp;rft.au=National+Cancer+Institute&amp;rft.btitle=General+Information+About+Chronic+Lymphocytic+Leukemia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2FCLL%2Fhealthprofessional%2Fpage1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/leukaemia-cll/">"Chronic lymphocytic leukaemia (CLL) statistics"</a>. <i>Cancer Research UK</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Chronic+lymphocytic+leukaemia+%28CLL%29+statistics&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fcancer-info%2Fcancerstats%2Ftypes%2Fleukaemia-cll%2F&amp;rft.jtitle=Cancer+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><span class="citation journal">Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, O'Connor SJ, Richards SJ, Morgan GJ, Jack AS, Hillmen P (July 2002). <a rel="nofollow" class="external text" href="http://www.bloodjournal.org/cgi/pmidlookup?view=long&amp;pmid=12091358">"Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts"</a>. <i>Blood</i> <b>100</b> (2): 635–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood.V100.2.635">10.1182/blood.V100.2.635</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12091358">12091358</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Monoclonal+B+lymphocytes+with+the+characteristics+of+%22indolent%22+chronic+lymphocytic+leukemia+are+present+in+3.5%25+of+adults+with+normal+blood+counts&amp;rft.date=July+2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloodjournal.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D12091358&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V100.2.635&amp;rft_id=info%3Apmid%2F12091358&amp;rft.issue=2&amp;rft.jtitle=Blood&amp;rft.pages=635-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn0-7817-5007-5-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn0-7817-5007-5_59-0">^</a></b></span> <span class="reference-text"><span class="citation book">Turgeon, Mary Louise (2005). <i>Clinical hematology: theory and procedures</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. p.&#160;283. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-5007-5" title="Special:BookSources/0-7817-5007-5">0-7817-5007-5</a>. <q>Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and Lymphoid Tissues. 2001, p. 2001.)</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.btitle=Clinical+hematology%3A+theory+and+procedures&amp;rft.date=2005&amp;rft.genre=book&amp;rft.isbn=0-7817-5007-5&amp;rft.pages=283&amp;rft.place=Hagerstown%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&amp;sid=150fea5ac37ad66e06bdb4f940a0e0dc&amp;rgn=div8&amp;view=text&amp;node=38:1.0.1.1.4.1.65.117&amp;idno=38">http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&amp;sid=150fea5ac37ad66e06bdb4f940a0e0dc&amp;rgn=div8&amp;view=text&amp;node=38:1.0.1.1.4.1.65.117&amp;idno=38</a>&gt;</span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation journal">Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, Deambrogi C, Ricca I, Rocci A, Ferrero S, Bernocco E, Capello D, De Paoli L, Bergui L, Boi M, Omedè P, Massaia M, Tarella C, Passera R, Boccadoro M, Gaidano G, Ladetto M (June 2009). "Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.". <i>Leukemia</i> <b>23</b> (6): 1062–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fleu.2008.399">10.1038/leu.2008.399</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19340005">19340005</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Telomere+length+is+an+independent+predictor+of+survival%2C+treatment+requirement+and+Richter%27s+syndrome+transformation+in+chronic+lymphocytic+leukemia.&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fleu.2008.399&amp;rft_id=info%3Apmid%2F19340005&amp;rft.issue=6&amp;rft.jtitle=Leukemia&amp;rft.pages=1062-72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation news">Auer, Holly (August 10, 2011). <a rel="nofollow" class="external text" href="http://www.uphs.upenn.edu/news/News_Releases/2011/08/t-cells/">"Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report"</a>. <a href="/wiki/University_of_Pennsylvania_School_of_Medicine" title="University of Pennsylvania School of Medicine" class="mw-redirect">University of Pennsylvania School of Medicine</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 12,</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.au=Auer%2C+Holly&amp;rft.aufirst=Holly&amp;rft.aulast=Auer&amp;rft.btitle=Genetically+Modified+%22Serial+Killer%22+T+Cells+Obliterate+Tumors+in+Patients+with+Chronic+Lymphocytic+Leukemia%2C+Penn+Researchers+Report&amp;rft.date=August+10%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.uphs.upenn.edu%2Fnews%2FNews_Releases%2F2011%2F08%2Ft-cells%2F&amp;rft.pub=University+of+Pennsylvania+School+of+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NEJ-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-NEJ_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Porter DL, Levine BL, Kalos M, Bagg A, June CH (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3387277">"Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia"</a>. <i>N. Engl. J. Med.</i> <b>365</b> (8): 110810110014063. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1103849">10.1056/NEJMoa1103849</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3387277">3387277</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21830940">21830940</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Chimeric+Antigen+Receptor%E2%80%93Modified+T+Cells+in+Chronic+Lymphoid+Leukemia&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3387277&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1103849&amp;rft_id=info%3Apmc%2F3387277&amp;rft_id=info%3Apmid%2F21830940&amp;rft.issue=8&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=110810110014063&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=365" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-STM-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-STM_64-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3393096">"T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia"</a>. <i>Sci. Transl. Med.</i> <b>3</b> (95): 95ra73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscitranslmed.3002842">10.1126/scitranslmed.3002842</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3393096">3393096</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21832238">21832238</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=T+Cells+with+Chimeric+Antigen+Receptors+Have+Potent+Antitumor+Effects+and+Can+Establish+Memory+in+Patients+with+Advanced+Leukemia&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3393096&amp;rft_id=info%3Adoi%2F10.1126%2Fscitranslmed.3002842&amp;rft_id=info%3Apmc%2F3393096&amp;rft_id=info%3Apmid%2F21832238&amp;rft.issue=95&amp;rft.jtitle=Sci.+Transl.+Med.&amp;rft.pages=95ra73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NPR-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-NPR_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NPR_65-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation news">Palca, Joe (August 11, 2011). <a rel="nofollow" class="external text" href="http://www.npr.org/blogs/health/2011/08/11/139536661/gene-therapy-breakthrough-trains-immune-system-to-fight-leukemia">"Gene Therapy Advance Trains Immune System To Fight Leukemia"</a>. <a href="/wiki/NPR" title="NPR">NPR</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 12,</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.aufirst=Joe&amp;rft.aulast=Palca&amp;rft.au=Palca%2C+Joe&amp;rft.btitle=Gene+Therapy+Advance+Trains+Immune+System+To+Fight+Leukemia&amp;rft.date=August+11%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.npr.org%2Fblogs%2Fhealth%2F2011%2F08%2F11%2F139536661%2Fgene-therapy-breakthrough-trains-immune-system-to-fight-leukemia&amp;rft.pub=NPR&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><span class="citation news">Bazell, Robert (August 10, 2011). <a rel="nofollow" class="external text" href="http://www.msnbc.msn.com/id/44090512/">"New leukemia treatment exceeds 'wildest expectations<span style="padding-right:0.2em;">'</span>"</a>. <a href="/wiki/MSNBC" title="MSNBC">MSNBC</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 12,</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.au=Bazell%2C+Robert&amp;rft.aufirst=Robert&amp;rft.aulast=Bazell&amp;rft.btitle=New+leukemia+treatment+exceeds+%27wildest+expectations%27&amp;rft.date=August+10%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.msnbc.msn.com%2Fid%2F44090512%2F&amp;rft.pub=MSNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation news">DeNoon, Daniel J. (August 10, 2011). <a rel="nofollow" class="external text" href="http://www.webmd.com/cancer/news/20110810/gene-therapy-cures-adult-leukemia">"Gene Therapy Cures Adult Leukemia"</a>. <a href="/wiki/WebMD" title="WebMD">WebMD</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 12,</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.au=DeNoon%2C+Daniel+J.&amp;rft.aufirst=Daniel+J.&amp;rft.aulast=DeNoon&amp;rft.btitle=Gene+Therapy+Cures+Adult+Leukemia&amp;rft.date=August+10%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.webmd.com%2Fcancer%2Fnews%2F20110810%2Fgene-therapy-cures-adult-leukemia&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><span class="citation news">Beasly, Deena (August 10, 2011). <a rel="nofollow" class="external text" href="http://www.reuters.com/article/2011/08/10/us-leukemia-genetherapy-idUSTRE7795NT20110810">"Gene therapy shown to destroy leukemia tumors"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 12,</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.au=Beasly%2C+Deena&amp;rft.aufirst=Deena&amp;rft.aulast=Beasly&amp;rft.btitle=Gene+therapy+shown+to+destroy+leukemia+tumors&amp;rft.date=August+10%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2F2011%2F08%2F10%2Fus-leukemia-genetherapy-idUSTRE7795NT20110810&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.nytimes.com/2011/08/11/health/research/11cancer.html">"Treatment for Leukemia Is Showing Early Promise"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a>. August 11, 2011. p.&#160;A15<span class="reference-accessdate">. Retrieved <span class="nowrap">August 12,</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Treatment+for+Leukemia+Is+Showing+Early+Promise&amp;rft.date=August+11%2C+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2011%2F08%2F11%2Fhealth%2Fresearch%2F11cancer.html&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=A15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Urba WJ, Longo DL (2011). "Redirecting T Cells". <i>N. Engl. J. Med.</i> <b>365</b> (8): 110810110014063. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMe1106965">10.1056/NEJMe1106965</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21830939">21830939</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Redirecting+T+Cells&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMe1106965&amp;rft_id=info%3Apmid%2F21830939&amp;rft.issue=8&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=110810110014063&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=365" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid25050922-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25050922_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">ten Hacken E, Burger JA (2014). "Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies". <i>Pharmacol. Ther.</i> <b>144</b> (3): 338–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.pharmthera.2014.07.003">10.1016/j.pharmthera.2014.07.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25050922">25050922</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AB-cell+chronic+lymphocytic+leukemia&amp;rft.atitle=Microenvironment+dependency+in+Chronic+Lymphocytic+Leukemia%3A+The+basis+for+new+targeted+therapies&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2014.07.003&amp;rft_id=info%3Apmid%2F25050922&amp;rft.issue=3&amp;rft.jtitle=Pharmacol.+Ther.&amp;rft.pages=338-48&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=144" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit&amp;section=23" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=62">Chronic Lymphocytic Leukemia</a> at <a href="/wiki/American_Cancer_Society" title="American Cancer Society">American Cancer Society</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancerinfo/pdq/treatment/CLL/patient/">General information about CLL</a> from the US <a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">National Cancer Institute</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.net/cancer-types/leukemia-chronic-lymphocytic-cll">Cancer.Net: Chronic Lymphocytic Leukemia</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymphoid_malignancy" title="Template talk:Lymphoid malignancy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymphoid_malignancy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology#.289590.E2.80.939999.29_Hematologic_.28Leukemias.2C_Lymphomas_and_related_disorders.29" title="International Classification of Diseases for Oncology">ICD-O 9590–9989</a>, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81.E2.80.93C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81–C96</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200.E2.80.93208.29" title="List of ICD-9 codes 140–239: neoplasms">200–208</a>)<br />
<a href="/wiki/Lymphocyte" title="Lymphocyte">Lymphoid</a>/<a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative</a>, <a href="/wiki/Lymphoma" title="Lymphoma">Lymphomas</a>/<a href="/wiki/Lymphoid_leukemia" title="Lymphoid leukemia">Lymphoid leukemias</a> (9590–9739, 9800–9839)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_B_cell_neoplasms" title="Lymphoma">B cell</a><br />
(<a href="/wiki/B-cell_lymphoma" title="B-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/B-cell_leukemia" title="B-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD19" title="CD19">CD19</a>
<ul>
<li><a href="/wiki/CD20" title="CD20">CD20</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_B-cell_lymphoblastic_leukemia" title="Precursor B-cell lymphoblastic leukemia">Precursor B acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Naive_B_cell" title="Naive B cell">naive B cell</a></i> (<strong class="selflink">CLL/SLL</strong>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Mantle_zone" title="Mantle zone">mantle zone</a></i> (<a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD22" title="CD22">CD22</a>+</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/B-cell_prolymphocytic_leukemia" title="B-cell prolymphocytic leukemia">Prolymphocytic</a></li>
<li><i><a href="/wiki/CD11c" title="CD11c">CD11c+</a></i> (<a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD79A" title="CD79A">CD79a</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Germinal_center" title="Germinal center">germinal center</a>/<a href="/wiki/Follicular_B_cell" title="Follicular B cell">follicular B cell</a></i> (<a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular</a></li>
<li><a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's</a></li>
<li><a href="/wiki/GCB_DLBCL" title="GCB DLBCL" class="mw-redirect">GCB DLBCL</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Marginal_zone_B-cell_lymphoma" title="Marginal zone B-cell lymphoma">marginal zone</a>/<a href="/wiki/Marginal-zone_B_cell" title="Marginal-zone B cell" class="mw-redirect">marginal-zone B cell</a></i> (<a href="/wiki/Splenic_marginal_zone_lymphoma" title="Splenic marginal zone lymphoma">Splenic marginal zone</a></li>
<li><a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT</a></li>
<li><a href="/wiki/Nodal_marginal_zone_B_cell_lymphoma" title="Nodal marginal zone B cell lymphoma">Nodal marginal zone</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reed-Sternberg_cell" title="Reed-Sternberg cell" class="mw-redirect">RS</a> (<a href="/wiki/CD15" title="CD15">CD15</a>+, <a href="/wiki/CD30" title="CD30">CD30</a>+)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Classic Hodgkin's lymphoma</a> (<a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">Nodular sclerosis</a>)</li>
<li><i><a href="/wiki/CD20" title="CD20">CD20+</a></i> (<a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">Nodular lymphocyte predominant Hodgkin's lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Plasma_cell_dyscrasia" title="Plasma cell dyscrasia">PCDs</a>/<a href="/wiki/Paraproteinemia" title="Paraproteinemia">PP</a><br />
(<a href="/wiki/CD38" title="CD38">CD38</a>+/<a href="/wiki/CD138" title="CD138" class="mw-redirect">CD138</a>+)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>see <a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">immunoproliferative immunoglobulin disorders</a></i></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Kaposi%27s_sarcoma-associated_herpesvirus" title="Kaposi's sarcoma-associated herpesvirus">KSHV</a></i> (<a href="/wiki/Primary_effusion_lymphoma" title="Primary effusion lymphoma">Primary effusion</a>)</li>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Lymphomatoid_granulomatosis" title="Lymphomatoid granulomatosis">Lymphomatoid granulomatosis</a></li>
<li><a href="/wiki/Post-transplant_lymphoproliferative_disorder" title="Post-transplant lymphoproliferative disorder">Post-transplant lymphoproliferative disorder</a>)</li>
<li><i><a href="/wiki/HIV" title="HIV">HIV</a></i> (<a href="/wiki/AIDS-related_lymphoma" title="AIDS-related lymphoma">AIDS-related lymphoma</a>)</li>
<li><i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i> (<a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_B-cell_lymphoma" title="Cutaneous B-cell lymphoma">Cutaneous</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diffuse_large_B-cell_lymphoma" title="Diffuse large B-cell lymphoma">Diffuse large B-cell lymphoma</a></li>
<li><a href="/wiki/Intravascular_large_B-cell_lymphoma" title="Intravascular large B-cell lymphoma">Intravascular large B-cell lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_immunocytoma" title="Primary cutaneous immunocytoma">Primary cutaneous immunocytoma</a></li>
<li><a href="/wiki/Plasmacytoma" title="Plasmacytoma">Plasmacytoma</a></li>
<li><a href="/wiki/Plasmacytosis" title="Plasmacytosis">Plasmacytosis</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">T/NK</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/T_cell" title="T cell">T cell</a><br />
(<a href="/wiki/T-cell_lymphoma" title="T-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/T-cell_leukemia" title="T-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a>
<ul>
<li><a href="/wiki/CD4" title="CD4">CD4</a></li>
<li><a href="/wiki/CD8" title="CD8">CD8</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a>: <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_T-cell_lymphoblastic_leukemia" title="Precursor T-cell lymphoblastic leukemia" class="mw-redirect">Precursor T acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Prolymphocyte" title="Prolymphocyte">prolymphocyte</a></i> (<a href="/wiki/T-cell_prolymphocytic_leukemia" title="T-cell prolymphocytic leukemia">Prolymphocytic</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/CD30" title="CD30">CD30+</a></i> (<a href="/wiki/Anaplastic_large-cell_lymphoma" title="Anaplastic large-cell lymphoma">Anaplastic large-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_T-cell_lymphoma" title="Cutaneous T-cell lymphoma" class="mw-redirect">Cutaneous</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">MF+variants</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>indolent:</i> <a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">Mycosis fungoides</a></li>
<li><a href="/wiki/Pagetoid_reticulosis" title="Pagetoid reticulosis">Pagetoid reticulosis</a></li>
<li><a href="/wiki/Granulomatous_slack_skin" title="Granulomatous slack skin">Granulomatous slack skin</a></li>
</ul>
<p><i>aggressive:</i> <a href="/wiki/S%C3%A9zary_disease" title="Sézary disease">Sézary disease</a></p>
<ul>
<li><a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Non-MF</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>-: <a href="/wiki/Non-mycosis_fungoides_CD30%E2%88%92_cutaneous_large_T-cell_lymphoma" title="Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma">Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma</a></li>
<li><a href="/wiki/Pleomorphic_T-cell_lymphoma" title="Pleomorphic T-cell lymphoma">Pleomorphic T-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type B</a></li>
</ul>
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>+: <a href="/wiki/CD30%2B_cutaneous_T-cell_lymphoma" title="CD30+ cutaneous T-cell lymphoma">CD30+ cutaneous T-cell lymphoma</a></li>
<li><a href="/wiki/Secondary_cutaneous_CD30%2B_large_cell_lymphoma" title="Secondary cutaneous CD30+ large cell lymphoma" class="mw-redirect">Secondary cutaneous CD30+ large cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other <a href="/wiki/Peripheral_T-cell_lymphoma" title="Peripheral T-cell lymphoma">peripheral</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hepatosplenic_T-cell_lymphoma" title="Hepatosplenic T-cell lymphoma">Hepatosplenic</a></li>
<li><a href="/wiki/Angioimmunoblastic_T-cell_lymphoma" title="Angioimmunoblastic T-cell lymphoma">Angioimmunoblastic</a></li>
<li><a href="/wiki/Enteropathy-associated_T-cell_lymphoma" title="Enteropathy-associated T-cell lymphoma">Enteropathy-associated T-cell lymphoma</a></li>
<li><a href="/wiki/Peripheral_T-cell_lymphoma-Not-Otherwise-Specified" title="Peripheral T-cell lymphoma-Not-Otherwise-Specified" class="mw-redirect">Peripheral T-cell lymphoma-Not-Otherwise-Specified</a> (<a href="/wiki/Lennert_lymphoma" title="Lennert lymphoma">Lennert lymphoma</a>)</li>
<li><a href="/wiki/Subcutaneous_T-cell_lymphoma" title="Subcutaneous T-cell lymphoma">Subcutaneous T-cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Human_T-lymphotropic_virus_1" title="Human T-lymphotropic virus 1">HTLV-1</a></i> (<a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">NK cell</a>/<br />
(most <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aggressive_NK-cell_leukemia" title="Aggressive NK-cell leukemia">Aggressive NK-cell leukemia</a></li>
<li><a href="/wiki/Blastic_NK_cell_lymphoma" title="Blastic NK cell lymphoma">Blastic NK cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">T or NK</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Extranodal_NK-T-cell_lymphoma" title="Extranodal NK-T-cell lymphoma" class="mw-redirect">Extranodal NK-T-cell lymphoma</a>/<a href="/wiki/Angiocentric_lymphoma" title="Angiocentric lymphoma" class="mw-redirect">Angiocentric lymphoma</a>)</li>
<li><a href="/wiki/Large_granular_lymphocytic_leukemia" title="Large granular lymphocytic leukemia">Large granular lymphocytic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Lymphoid+myeloid</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphocytosis" title="Lymphocytosis">Lymphocytosis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative disorders</a> (<a href="/wiki/X-linked_lymphoproliferative_disease" title="X-linked lymphoproliferative disease">X-linked lymphoproliferative disease</a></li>
<li><a href="/wiki/Autoimmune_lymphoproliferative_syndrome" title="Autoimmune lymphoproliferative syndrome">Autoimmune lymphoproliferative syndrome</a>)</li>
<li><a href="/wiki/Leukemoid_reaction" title="Leukemoid reaction">Leukemoid reaction</a></li>
<li><a href="/wiki/Diffuse_infiltrative_lymphocytosis_syndrome" title="Diffuse infiltrative lymphocytosis syndrome">Diffuse infiltrative lymphocytosis syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a>
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_bandlike_and_perivascular_patterns" title="Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns" class="mw-redirect">with bandlike and perivascular patterns</a></li>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_nodular_pattern" title="Cutaneous lymphoid hyperplasia with nodular pattern" class="mw-redirect">with nodular pattern</a></li>
</ul>
</li>
<li><a href="/wiki/Jessner_lymphocytic_infiltrate_of_the_skin" title="Jessner lymphocytic infiltrate of the skin" class="mw-redirect">Jessner lymphocytic infiltrate of the skin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymph_immune_and_complement_navs" title="Template:Lymph immune and complement navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymph_immune_and_complement_navs" title="Template talk:Lymph immune and complement navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymph_immune_and_complement_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Immune_system" title="Immune system">immune system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">Physiology</a>
<ul>
<li><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cells</a></li>
<li><a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">autoantigens</a></li>
<li><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">autoantibodies</a></li>
<li><a href="/wiki/Template:Complement_system" title="Template:Complement system">complement</a></li>
<li><a href="/wiki/Template:Surface_antigens" title="Template:Surface antigens">surface antigens</a></li>
<li><a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">IG receptors</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Allergic_conditions" title="Template:Allergic conditions">Allergies</a></li>
<li><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">Immunodeficiency</a></li>
<li><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">Immunoproliferative immunoglobulin disorders</a></li>
<li><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">Hypersensitivity and autoimmune disorders</a></li>
<li><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">Neoplasms and cancer</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antihistamines" title="Template:Antihistamines">antihistamines</a></li>
<li><a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">immunostimulants</a></li>
<li><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">immunosuppressants</a></li>
<li><a href="/wiki/Template:Monoclonals_for_immune_system" title="Template:Monoclonals for immune system">monoclonal antibodies</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Small_blue_round_cell_tumors" title="Template:Small blue round cell tumors"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Small_blue_round_cell_tumors" title="Template talk:Small blue round cell tumors"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Small_blue_round_cell_tumors&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Small-blue-round-cell_tumor" title="Small-blue-round-cell tumor">Small-blue-round-cell tumors</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">B-cell chronic lymphocytic leukemia</strong></li>
<li><a href="/wiki/Hepatoblastoma" title="Hepatoblastoma">Hepatoblastoma</a></li>
<li><a href="/wiki/Rhabdomyosarcoma" title="Rhabdomyosarcoma">Rhabdomyosarcoma</a></li>
<li><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a></li>
<li><a href="/wiki/Neuroblastoma" title="Neuroblastoma">Neuroblastoma</a></li>
<li><a href="/wiki/Retinoblastoma" title="Retinoblastoma">Retinoblastoma</a></li>
<li><a href="/wiki/Wilms%27_tumor" title="Wilms' tumor">Wilms' tumor</a></li>
<li><a href="/wiki/Desmoplastic_small_round_cell_tumor" title="Desmoplastic small round cell tumor" class="mw-redirect">Desmoplastic small round cell tumor</a></li>
<li><a href="/wiki/Medulloblastoma" title="Medulloblastoma">Medulloblastoma</a></li>
<li><a href="/wiki/Primitive_neuroectodermal_tumor" title="Primitive neuroectodermal tumor">Primitive neuroectodermal tumor</a> (<b>PNET</b>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1024
CPU time usage: 0.912 seconds
Real time usage: 1.029 seconds
Preprocessor visited node count: 4731/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 261130/2097152 bytes
Template argument size: 2631/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 4/500
Lua time usage: 0.349/10.000 seconds
Lua memory usage: 3.97 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  805.098      1 - -total
 55.53%  447.075      1 - Template:Reflist
 24.52%  197.404     48 - Template:Cite_journal
 18.36%  147.826      9 - Template:Navbox
 10.69%   86.039      1 - Template:Infobox_disease
  9.40%   75.715      1 - Template:Infobox
  8.25%   66.410      1 - Template:Hematological_malignancy_histology
  7.13%   57.405      8 - Template:Cite_web
  5.32%   42.799      3 - Template:Fix
  4.72%   37.989      1 - Template:Redirect
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:454231-0!*!0!!en!4!* and timestamp 20150711131122 and revision id 670152435
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;oldid=670152435">https://en.wikipedia.org/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;oldid=670152435</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Chronic_lymphocytic_leukemia" title="Category:Chronic lymphocytic leukemia">Chronic lymphocytic leukemia</a></li><li><a href="/wiki/Category:Small_blue_round_cell_tumor" title="Category:Small blue round cell tumor">Small blue round cell tumor</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_using_citations_with_accessdate_and_no_URL" title="Category:Pages using citations with accessdate and no URL">Pages using citations with accessdate and no URL</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_accuracy_disputes" title="Category:All accuracy disputes">All accuracy disputes</a></li><li><a href="/wiki/Category:Articles_with_disputed_statements_from_February_2015" title="Category:Articles with disputed statements from February 2015">Articles with disputed statements from February 2015</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2008" title="Category:Articles with unsourced statements from July 2008">Articles with unsourced statements from July 2008</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2013" title="Category:Articles with unsourced statements from July 2013">Articles with unsourced statements from July 2013</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=B-cell+chronic+lymphocytic+leukemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=B-cell+chronic+lymphocytic+leukemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/B-cell_chronic_lymphocytic_leukemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:B-cell_chronic_lymphocytic_leukemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/B-cell_chronic_lymphocytic_leukemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/B-cell_chronic_lymphocytic_leukemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/B-cell_chronic_lymphocytic_leukemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;oldid=670152435" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1088156" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=B-cell_chronic_lymphocytic_leukemia&amp;id=670152435" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=B-cell+chronic+lymphocytic+leukemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=B-cell+chronic+lymphocytic+leukemia&amp;oldid=670152435&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%A7%D8%A8%D9%8A%D8%B6%D8%A7%D8%B6_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D9%84%D9%8A%D9%85%D9%81%D8%A7%D9%88%D9%8A_%D8%A7%D9%84%D9%85%D8%B2%D9%85%D9%86" title="ابيضاض الدم الليمفاوي المزمن – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Chronische_lymphatische_Leuk%C3%A4mie" title="Chronische lymphatische Leukämie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Leucemia_linf%C3%A1tica_cr%C3%B3nica" title="Leucemia linfática crónica – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%84%D9%88%D8%B3%D9%85%DB%8C_%D9%85%D8%B2%D9%85%D9%86_%D9%84%D9%86%D9%81%D9%88%D8%A6%DB%8C%D8%AF%DB%8C" title="لوسمی مزمن لنفوئیدی – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Leuc%C3%A9mie_lympho%C3%AFde_chronique" title="Leucémie lymphoïde chronique – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%A7%8C%EC%84%B1_%EB%A6%BC%ED%94%84%EB%AA%A8%EA%B5%AC_%EB%B0%B1%ED%98%88%EB%B3%91" title="만성 림프모구 백혈병 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Kroni%C4%8Dna_limfocitna_leukemija" title="Kronična limfocitna leukemija – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Leucemia_linfatica_cronica" title="Leucemia linfatica cronica – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9C%D7%95%D7%A7%D7%9E%D7%99%D7%94_%D7%9C%D7%99%D7%9E%D7%A4%D7%95%D7%A6%D7%99%D7%98%D7%99%D7%AA_%D7%9B%D7%A8%D7%95%D7%A0%D7%99%D7%AA" title="לוקמיה לימפוציטית כרונית – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/L%C4%97tin%C4%97_limfoleukemija" title="Lėtinė limfoleukemija – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Kr%C3%B3nikus_limfocit%C3%A1s_leuk%C3%A9mia" title="Krónikus limfocitás leukémia – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Chronische_lymfatische_leukemie" title="Chronische lymfatische leukemie – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E6%85%A2%E6%80%A7%E3%83%AA%E3%83%B3%E3%83%91%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85" title="慢性リンパ性白血病 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Przewlek%C5%82e_bia%C5%82aczki_limfatyczne" title="Przewlekłe białaczki limfatyczne – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Leucemia_linfoide_cr%C3%B4nica" title="Leucemia linfoide crônica – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%A5%D1%80%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D0%BB%D0%B8%D0%BC%D1%84%D0%BE%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Хронический лимфолейкоз – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Kroni%C4%8Dna_limfocitna_levkemija" title="Kronična limfocitna levkemija – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Hroni%C4%8Dna_limfati%C4%8Dna_leukemija" title="Hronična limfatična leukemija – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Hroni%C4%8Dna_limfocitna_leukemija" title="Hronična limfocitna leukemija – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Krooninen_lymfaattinen_leukemia" title="Krooninen lymfaattinen leukemia – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Kronisk_lymfatisk_leukemi" title="Kronisk lymfatisk leukemi – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-te"><a href="//te.wikipedia.org/wiki/%E0%B0%95%E0%B1%8D%E0%B0%B0%E0%B0%BE%E0%B0%A8%E0%B0%BF%E0%B0%95%E0%B1%8D_%E0%B0%B2%E0%B0%BF%E0%B0%82%E0%B0%AA%E0%B1%8B%E0%B0%B8%E0%B1%88%E0%B0%9F%E0%B0%BF%E0%B0%95%E0%B1%8D_%E0%B0%B2%E0%B1%81%E0%B0%95%E0%B1%87%E0%B0%AE%E0%B0%BF%E0%B0%AF%E0%B0%BE" title="క్రానిక్ లింపోసైటిక్ లుకేమియా – Telugu" lang="te" hreflang="te">తెలుగు</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B9%80%E0%B8%A1%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B8%82%E0%B8%B2%E0%B8%A7%E0%B8%A5%E0%B8%B4%E0%B8%A1%E0%B9%82%E0%B8%9F%E0%B9%84%E0%B8%8B%E0%B8%95%E0%B9%8C%E0%B9%81%E0%B8%9A%E0%B8%9A%E0%B9%80%E0%B8%A3%E0%B8%B7%E0%B9%89%E0%B8%AD%E0%B8%A3%E0%B8%B1%E0%B8%87%E0%B8%8A%E0%B8%99%E0%B8%B4%E0%B8%94%E0%B8%9A%E0%B8%B5%E0%B9%80%E0%B8%8B%E0%B8%A5%E0%B8%A5%E0%B9%8C" title="มะเร็งเม็ดเลือดขาวลิมโฟไซต์แบบเรื้อรังชนิดบีเซลล์ – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A5%D1%80%D0%BE%D0%BD%D1%96%D1%87%D0%BD%D0%B8%D0%B9_%D0%BB%D1%96%D0%BC%D1%84%D0%BE%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Хронічний лімфолейкоз – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-ur"><a href="//ur.wikipedia.org/wiki/%D8%B3%DB%8C%D8%A7%D9%84%D9%88%DB%8C%D8%A7%D8%AA%DB%8C_%D8%A7%D8%A8%DB%8C%D8%B6%D8%A7%D8%B6%D9%90_%D9%85%D8%B2%D9%85%D9%86" title="سیالویاتی ابیضاضِ مزمن – Urdu" lang="ur" hreflang="ur">اردو</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1088156#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 6 July 2015, at 05:17.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=B-cell_chronic_lymphocytic_leukemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":123,"wgHostname":"mw1069"});
}</script>
	</body>
</html>
